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Summary 
Collagens are structural proteins consisting of (Gly-X-Y)n repeat units and have been identified in 
vertebrates,  invertebrates, bacteria,  fungi and viruses. In mammals, collagens occur in connective 
tissues, bones and tendons, in which they confer stability and tensile strength. In tendons, collagen fibrils 
associate to collagen fibers, which are the structural components of collagen fascicles. Collagen fibrils are 
made of three collagen α-chains, a structural entity that results in the tremendous strength of collagen. 
Even though collagens were identified more than a century ago, several molecular properties have 
remained unexplored. Human collagens are posttranslationally modified by prolyl- and lysyl 
hydroxylation and the subsequent glycosylation of hydroxylysine residues. While prolyl hydroxylation 
provides stabilization of the triple helical structure of collagen, lysyl hydroxylation can be additionally 
modified by the lysyl-oxidase enzyme family to crosslink collagen molecules. The function of collagen 
glycosylation however is unknown.  
β(1-O)galactosylation of collagen is conferred by the two paralogous enzymes GLT25D1 and GLT25D2 in 
the endoplasmic reticulum.  While GLT25D1 is expressed ubiquitously, GLT25D2 is restricted to the brain 
and skeletal muscles. The galactosyl residue can be further elongated with glucose to the Glc(α1-
2)Gal(β1-O)Hyl disaccharide. The responsible glucosyltransferase has not been identified yet. Several 
functions have been assigned to collagen glycosylation including folding, secretion and receptor 
interactions with integrins or the urokinase-type plasminogen activator receptor associated protein. No 
study however has addressed the function of GLT25D1 or GLT25D2. 
In this thesis, we used the CRISPR/Cas9 system to inactivate GLT25D1 and GLT25D2 in osteosarcoma cell 
lines. Glycosyltransferase activity was significantly reduced in GLT25D1-null cells to 3 – 7% of the activity 
measured in wild type cells. Interestingly, collagen glycosylation in GLT25D1-null cells as was measured 
by HPLC amino acid analysis was only reduced by 40 – 60% indicating a potential compensation 
mechanism. We found a threefold upregulation of GLT25D2 in GLT25D1-null cells by quantitative PCR 
analysis. We further found increased collagen type I expression levels in GLT25D1-null cells but not in 
GLT25D2-null cells as was assessed by quantitative PCR analysis, Western blot analysis and 
immunofluorescence. Expression levels of the collagen types III and V remained unchanged. In contrast 
to previous studies, we detected normal collagen secretion and folding as measured by a pulse chase 
experiment and circular dichroism.  
In the second part of the thesis, we identified and analyzed collagens from nucleocytoplasmic large DNA 
viruses in silico. Collagen-like genes have previously been described in the Acanthamoeba polyphaga 
mimivirus. Based on the recent discovery of further members of the Mimiviridae family, we identified 
142 collagen-like genes in the genome of 60 nucleocytoplasmic large DNA viruses. Analysis of the 
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collagen-like proteins revealed distinct phylogenetic origins for Pithoviridae and Pandoraviridae but a 
shared phylogenetic origin for Mimiviridae and Megaviridae. Sequence analysis of the viral collagen-like 
proteins hint at three distinct mechanisms for triple helix stabilization. Most probably, Pandoraviridae 
use prolyl hydroxylation at the Y position of Gly-X-Y repeats to stabilize collagen folding, similar to animal 
collagens. Pithoviridae in contrast incorporate threonine at the Y position of 50% of all Gly-X-Y repeats, 
indicating a similar stabilization mechanism as is found in the deep-sea worm Riftia pachyptila, which 
uses glycosylated threonine residues to increase triple-helical stability. Mimiviridae and Megaviridae 
show a unique pattern of oppositely charged amino acids at the X and Y position, which could result in 
electrostatic stabilization of the collagen triple helix. These models were generated in silico, however, 
experimental work is still required in order to characterize the collagen-like proteins from giant viruses 
and to support the interpretation of our data. 
In the third part of the thesis, we used viral enzymes to produce posttranslationally modified collagens 
in E. coli. Giant viruses not only encode collagen-like proteins but also collagen modifying enzymes. 
Previously, a viral prolyl 4-hydroxylase and a bifunctional collagen lysyl hydroxylase and 
glucosyltransferase were identified in the genome of the mimivirus. We expressed human collagen 
together with these viral enzymes and showed posttranslational modifications at lysine and proline 
residues resulting in improved triple helical stability compared to unmodified collagen. We further used 
the recombinant collagen as an extracellular matrix substitute for the growth of human umbilical vein 
cells proving biocompatibility of the recombinant human collagen. In the future, this expression system 
could be used for the large-scale production of recombinant human collagen suitable for a variety of 
biomedical applications. 
In conclusion, we contributed to the general understanding of the diversity of collagens and collagen 
modifications. The results will be beneficial for further studies on collagen glycosylation in more complex 
model systems. The in silico studies on viral collagens help resolving the phylogeny of collagens and sets 
a fundamental basis for experimental work to identify the functional role of viral collagens. 
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Zusammenfassung 
Kollagene sind strukturelle Proteine, die durch den Baustein der Aminosäuren (Gly-X-Y)n gekennzeichnet 
sind und in Vertebraten, Invertebraten, Bakterien, Pilzen und in Viren vorkommen. Bei Säugetieren 
kommt Kollagen in Bindegewebe, Knochen und Sehnen vor, in welchen sie durch ihre verdrillte Struktur 
für die Zugfestigkeit und die Stabilität des Gewebes verantwortlich sind. Sehnen sind zum Beispiel aus 
Faszikeln aufgebaut, welche aus Kollagenfasern bestehen, die wiederum in Kollagenfibrillen unterteilt 
sind. Letztere sind durch drei Kollagen α-Ketten charakterisiert, ein strukturelles Konstrukt, das zur 
enormen Stabilität des Gewebes führt. Obwohl Kollagene schon vor über einem Jahrhundert beschrieben 
worden sind, sind einige molekulare Eigenschaften noch immer unerforscht. Humane Kollagene sind 
posttranslational modifiziert mit Prolyl- und Lysyl Hydroxylierung und anschliessender Glykosylierung von 
spezifischen Hydroxylysin Seitenketten. Prolyl Hydroxylierung steigert die Stabilität der Kollagen 
Tripelhelix. Lysyl Hydroxylierung dient den Lysyl Oxidase Enzymen als Substrat, welche die verschiedenen 
Kollagenketten kovalent miteinander verknüpfen. Die physiologische Funktion der 
Kollagenglykosylierung ist allerdings unbekannt. 
Der Kern der Kollagenglykosylierung besteht aus β(1-O)Galaktose und wird von den Enzymen GLT25D1 
und GLT25D2 im endoplasmatischen Retikulum übertragen. GLT25D1 wird in den meisten Zellen 
ubiquitär exprimiert. Im Gegensatz dazu wird GLT25D2 lediglich im Gehirn und in kleineren Mengen in 
Skelettmuskelzellen exprimiert. Die Galaktose auf Hydroxylysin kann mit Glukose zum Disaccharid Glc(α1-
2)Gal(β1-O)Hyl erweitert werden. Obwohl die Hauptfunktion der Kollagenglykosylierung unbekannt ist, 
wurde die Beteiligung dieser posttranslationalen Modifikation in einigen Studien geprüft. Demnach spielt 
die Glykosylierung in der Faltung und in der Sekretion von Kollagenen sowie in der Interaktion von 
Kollagenen mit Rezeptoren wie zum Beispiel Integrinen oder dem Urokinase-Typ Plasminogen 
assoziierten Rezeptor Protein eine Rolle. Keine Studie erforschte bisher die Funktionen von GLT25D1 oder 
GLT25D2.  
In dieser Dissertation verwendeten wir das CRISPR/Cas9 System um GLT25D1 und GLT25D2 in 
Osteosarkomazellen zu inaktivieren. Die Glykosyltransferaseaktivität war in GLT25D1-null Zellen 
signifikant um 93 – 97% reduziert. Jedoch detektierten wir bei Messungen von der 
Aminosäurezusammensetzung in Kollagenen von GLT25D1-null Zellen weiterhin 40 – 60% der 
ursprünglichen Kollagenglykosylierung. Wir fanden eine dreifache Überregulierung von GLT25D2 in den 
GLT25D1-null Zellen, gemessen mit einer quantitativen PCR Analyse, welche die restliche Glykosylierung 
erklären könnte. Des Weiteren entdeckten wir erhöhte Kollagen Typ I Expressionslevel gemessen mit 
quantitativer PCR Analyse, mit Western Blot Analyse und mit Immunfluoreszenz. Die Expressionslevel von 
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Kollagen Typ III und V blieben unverändert. Anders als in vorhergehenden Studien berichtet wurde, 
konnten wir keinen Unterschied bei der Kollagensekretion oder der Faltung feststellen. 
Im zweiten Teil der Dissertation identifizierten und analysierten wir Kollagene von grossen 
nucleocytplasmatischen DNS Viren in silico. Kollagene wurden bereits im Genom vom Acanthamoeba 
polyphaga Mimivirus nachgewiesen. Aufgrund der Entdeckung von weiteren Mitgliedern der Familie der 
Mimiviridae, suchten wir in 60 Mitgliedern der grossen nucleocytoplasmatischen DNS Viren nach 
Kollagensequenzen und entdeckten 142 kollagenähnliche Proteine hauptsächlich in den Familien der 
Mimiviridae, Megaviridae, Pandoraviridae und im Pithovirus. Die phylogenetische Analyse von den 
kollagenähnlichen Proteinen zeigte drei verschiedene Abstammungen der Kollagene vom Pithovirus, den 
Pandoraviridae und einen gemeinsamen Ursprung der Mimiviridae und Megaviridae. Die Analyse der 
Aminosäurezusammensetzung der Kollagendomänen der kollagenähnlichen Proteine deutete auf drei 
unterschiedliche Mechanismen zur Tripelhelix Stabilisierung hin. Dabei inkorporieren Pithoviren in 50% 
der Y Position von den Gly-X-Y Einheiten Threonin, ähnlich wie der Tiefseewurm Riftia pachyptila. Dieser 
Tiefseewurm benutzt glykosylierte Threonine zur Stabilisierung der Tripelhelix. Pandoraviren besetzen 
die X und Y Position vor allem mit Prolin, ähnlich wie menschliche Kollagene. Im Gegensatz hierzu 
beinhalten kollagenähnliche Proteine der Mimiviridae und Megaviridae vor allem geladene Aminosäuren 
in der X und Y Position der Gly-X-Y Einheiten. Dies weist auf eine elektrostatische Stabilisierung der 
Kollagen Tripelhelix hin. Weil diese Ergebnisse in silico generiert wurden, werden experimentelle 
Arbeiten benötigt, um die kollagenähnlichen Proteine detailliert zu charakterisieren und um die 
Interpretation unsere Daten zu unterstützen. 
Im dritten Teil der Dissertation verwendeten wir virale Enzyme um posttranslational modifiziertes 
Kollagen in E. coli zu exprimieren. Grosse Viren besitzen nicht nur Kollagene, sondern auch Enzyme zur 
Modifikation der Kollagene. Frühere Studien identifizierten eine Prolyl 4-Hydroxylase und eine 
bifunktionelle Kollagen Lysyl Hydroxylase und Glukosyltransferase im Mimivirusgenom. Wir exprimierten 
humanes Kollagen Typ III zusammen mit diesen Enzymen und wiesen die posttranslationalen 
Modifikationen im Kollagen mittels HPLC-gestützter Aminosäurenanalyse nach. Die Modifikationen 
resultierten in einer höheren Stabilität verglichen mit unmodifiziertem Kollagen. Des Weiteren benutzten 
wir das rekombinante Kollagen zur Kultivierung von menschlichen Nabelschnurzellen und bewiesen 
dadurch dessen Biokompatibilität. Dieses Expressionssystem könnte in Zukunft für die Massenproduktion 
von rekombinanten Kollagenen für eine Vielfalt von biomedizinischen Anwendungen gebraucht werden.  
Zusammenfassend trugen wir mit dieser Dissertation zum Verständnis der Vielfalt von Kollagenen und 
kollagenmodifizierenden Enzymen bei. Die Resultate werden zukünftige Studien über 
Kollagenglykosylierung in komplexeren Organismen wie in Mäusen oder Zebrafischen unterstützen. Die 
Studie über virale Kollagene hilft zudem, die Herkunft und die funktionelle Rolle besser zu verstehen.  
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1. INTRODUCTION 
1.1 GENERAL INTRODUCTION TO COLLAGENS 
 
Collagens are a superfamily of extracellular matrix proteins serving as connective elements in various 
tissues in vertebrates and invertebrates. Collagens present the most abundant protein in the animal 
kingdom with 25 – 30% of all body proteins [2]. Collagens share a common repeated structural motif of 
(Gly-X-Y)n which is however not confined to collagens but also occur in other proteins, such as the 
mannose binding lectin or adiponectin [3]. In humans, 28 different collagen types have been identified 
which are encoded by more than 40 genes. Based on their quaternary structure and their function, they 
can be assigned to families of fibrillar collagens, fibril-associated collagens, network forming basement 
membrane collagens and transmembrane collagens (Table I) [4], [5]. Generally, collagens are modified 
by prolyl 3- and prolyl 4-hydroxylation, lysyl hydroxylation, and hydroxylysine O-glycosylation. These 
posttranslational modifications are essential for collagen folding, secretion, and for structural properties 
such as the tensile strength and tenacity as discussed later.  
Table I: human collagens and collagen-like proteins, adapted from [6]. 
Sub-family Members 
Fibrillar collagens Types I, II, III, V, VI, XI, XXIV, XXVII 
Fibril associated collagens Types IX, XII, XIV, XVI, XIX, XX, XXI 
Basement membrane collagens Type IV, VII, XV, XVIII 
Transmembrane collagens and 
collagen-like proteins 
Types XIII, XVII, XXIII, XXV, ectodysplasin, macrophage scavenger 
receptors I – III, MARCO, SRCL, gliomedin, CL-P1 
Collectins and ficolins Mannan binding lectin, surfactant protein A and D, conglutin, CL-
43, CL-16, CL-L1, CL-P1, L-, M- and H-ficolins 
Other collagen-like proteins Emu1 and 2, acetylcholinesterase tail subunit, adiponectin 
 
The family of fibrillar collagens consists of collagens type I, II, III, V, XI, XXIV and XXVII [7-9]. In humans, 
the most prevalent collagen is the fibrillar collagen type I, which presents up to 90% of the total collagen 
content. Collagen type I is found in tendons, skin, artery walls, cornea, fibrocartilage and in the organic 
part of bones and teeth. Up to 40% of collagen type I is found in the skin [10]. The second most prevalent 
collagen is collagen type II, which is restricted to cartilage tissue. Collagen type III is part of the granulation 
tissue and its expression is induced after tissue injury. It also is associated with collagen type I in skin and 
 9 
supports collagen I fibrillogenesis in  cardiovascular development [11]. The other fibrillar collagens are 
only found in minor amounts and their functions are poorly investigated. Some of these collagens are 
associated with either collagen type I or type II where they modify fibril diameter (collagen type XI) or 
help initiate collagen fibrils to assemble (collagen type V) [12, 13].  
Collagens have a unique structure, which is described in Figure 1. Mature collagen, as found in tendons, 
occurs in form of collagen fascicles, which are a composition of many collagen fibrils. Fibrils are composed 
of the procollagen triple helix, which consists of three procollagen molecules. The prototypical fibrillar 
collagen molecule carries a non-collagenous N-terminal propeptide domain, an N-terminal telopeptide, 
a collagenous domain, a C-terminal telopeptide and a non-collagenous C-terminal propeptide. The N- and 
C- terminal propeptides are cleaved before supramolecular assembly (See chapter 1.2) and collagen 
molecules are crosslinked by the enzymes from the family of lysyl oxidases to stabilize the collagen fibrils. 
 
 
 
 
The major part of fibrillar collagens is represented by the collagenous domains whose general amino acid 
composition consists of Gly-X-Y repeats ranging from 154 repeats in collagen type VIII up to 490 repeats 
in collagen type VII. The small amino acid glycine is a prerequisite for the tight packaging of three collagen 
molecules in a polyproline type II triple helix. Glycine enables a helical pitch of 10/3 to 7/2. This small 
pitch in turn allows interchain hydrogen bonds between glycine and proline to stabilize the triple helix 
and regulate the triple helix density [14]. The three-dimensional structure of the collagen helix is a 
prerequisite for interaction of collagens with other biomolecules such as integrins or heparin [15-17]. 
Collagen banding pattern as seen by electron microscopy 
Figure 1: Structural representation of fibrillar collagen type I. 
Shown are the different supramolecular assemblies of  collagen 
fascicles in tendon up to the molecular level. Propeptides with 
telopeptides are depicted in green, the collagenous domains in 
blue. Aldol and aldol-histidine crosslinks of collagen molecules 
are represented by black lines. 
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Numerous diseases, for instance Ehlers-Danlos syndrome and osteogenesis imperfecta, are associated 
with interruptions of the Gly-X-Y pattern caused by mutation of glycine into any other amino acid [18, 
19]. Collagenous domains are further characterized by a high proline content at position X and Y of the 
Gly-X-Y repeats. In human collagens approximately 22% of all residues are proline or hydroxyproline [20]. 
Due to the pyrrolidin ring of proline, procollagen strands pre-align in a helix-like manner and the entropic 
cost for triple helix formation is thereby reduced [21]. Many of the proline residues in the Y position are 
hydroxylated. Hydroxylation is conferred by the prolyl hydroxylases and stabilizes the triple helix 
essentially [22, 23] (see chapter 1.3.1).  
The collagenous domain of fibrillar collagens is interjacent of two non-collagenous propeptides. These 
propeptides prevent premature fibrillogenesis and are in most cases absent in mature collagen fibrils. 
Once the procollagen is secreted from the cell, the propeptides are removed by specific 
metalloproteases. Nevertheless, they play a crucial role in intracellular collagen folding, trimerization and 
secretion (see chapter 1.2).  A collagen triple helix can consist either of three identical chains as homo-
trimer or of three different chains as hetero-trimer. Since several procollagen molecules can be part of 
different types of collagen, the C-terminal propeptides serve as nucleation site and are the main factor 
of chain selectivity. Even though the human C-terminal propeptides of fibrillary collagens share a 
relatively high sequence homology of 46% [24], they build a distinct electrochemical environment 
allowing only specific procollagens to assemble [25]. Once the initial contact of three C-terminal 
propeptides is established, the collagen triple helix forms auto catalytically along the collagenous domain 
towards the N-terminal propeptide, driven by enthalpy via hydrophobic interactions [26]. The C- as well 
as the N-terminal propeptide contain cysteine residues that are intramolecularly crosslinked by disulfide 
bridges. Contrary to the propeptides, the small telopeptides remain attached to the collagenous domains 
after fibril formation (Fig. 1). They contain several hydroxylysine residues, which are intermolecularly 
cross-linked via lysyl oxidase enzymes [27].  
Most of the non-fibrillar collagens belong to the family of fibril-associated collagens with interrupted 
triple helices (FACIT). In comparison to fibrillar collagens, they contain several triple helical domains 
interrupted by non-collagenous domains and do not assemble into fibers (Fig. 2). FACIT collagens are 
associated with collagen fibrils and are low abundant (5 - 15% of cartilage collagens). The FACIT family 
comprises collagens type IX, XII, XIV, XVI, XIX, XX, XXI, and XXII. Collagen type XII and XIV are associated 
with type I collagen, collagen type IX and XVI with type II collagen (Fig. 2). These collagens have various 
functions, which are poorly investigated [28]. Since the propeptides are not cleaved in non-fibrillar 
collagens, they can act as anchor or linker of various fibrillar collagens [29]. Type IX collagen is further 
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attached to a glycosaminoglycan chain strengthening the collagen fibrils additionally.  Mutations in the 
collagen type IX lead to osteoarthritis [30] indicating non-functional cartilage composition.  
The most prominent member of the basement membrane type collagens is the non-fibrillar collagen type 
IV. It builds a network like lattice and is part of the basement membranes. Collagen type IV is associated 
with a variety of non-collagenous extracellular matrix proteins such as laminins, nidogens and the 
proteoglycan perlecan. Other non-fibrillar collagens such as type VII and XVII are also part of basal 
membranes and anchor epithelial cells. Mutations in type IV collagen result in the Alport syndrome [31], 
mutations in type VII collagen in epidermolysis bullosa [32], a disease originating from missing anchorage 
of the epithelium to the basement membrane.  
1.2 COLLAGEN BIOSYNTHESIS 
 
Collagen biosynthesis is a complex process composed of intracellular and extracellular steps (Fig. 3). The 
mechanisms are not yet fully understood and the steps that have been identified are mostly related to 
fibrillary collagens only. Pre-procollagen chains are translated in the rough endoplasmic reticulum (ER) 
where they undergo several posttranslational modifications such as prolyl and lysyl hydroxylation and N- 
and O-linked glycosylation [33]. Still in the ER, the C-terminal signal peptide is cleaved off and three 
monomeric pro-collagens associate at the C-terminal propeptides. The C-terminal propeptides are 
responsible for the monomer association and chain selectivity. Four cysteine residues in each C-terminal 
propeptide are intramolecularly linked via disulfide bonds formed by the protein disulfide isomerase. The 
associated propeptides are further intermolecularly linked by another six disulfide bonds. Propeptide 
association initiates a zipper like trimerization of the three procollagen molecules from the C- to the N-
terminus. The trimerization process is controlled by a peptidyl-prolyl-cis-trans-isomerase and is assisted 
by the molecular chaperones HSP47, GRP78 and Grp94. These chaperones bind incorrectly folded 
procollagen and prevent premature secretion [34]. Furthermore, the N-terminal signal peptide is cleaved 
Figure 2: Structural representation of FACIT collagens. Collagen type IX (purple) with non-collagenous domains 
(violet ovals) associated to collagen type II (yellow). Collagens are linked to each other via aldol and aldol-
histidine linkages (black). Collagen type IX is attached to a glycosaminoglycan chain (cyan). 
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off before the ER resident integral membrane protein Tango1 targets the procollagen for COPII coated 
transport to the Golgi apparatus [35]. However, Tango1 only targets collagen type VII and is not involved 
in collagen type I secretion [35]. The mechanism of targeting collagen type I for the transport to the Golgi 
apparatus is unknown.  
Regular COPII coated transport vesicles are restricted to molecules < 100 nm and hence not suitable for 
transporting 300 nm procollagens. The COPII coat consists of a structured grid composed of the proteins 
SEC13 and SEC31. A small pool of the SEC31 proteins can be ubiquitinylated by the ubiquitin ligase CUL3-
KLHL12 [36]. This posttranslational modification results in a structural change in the COPII coat and 
induces the formation of vesicles with an increased diameter of up to 500 nm, which is large enough to 
accommodate procollagen molecules [37]. The exit route of collagen from the trans Golgi network to the 
cell surface is unknown [38].  
After or during the late phase of the transport to the outside of the cell, the procollagen molecules are 
further modified. This step involves trimming of the N-terminal propeptide by ADAMTS2 [39], as well as 
trimming of the C-terminal propeptide by the procollagen C-terminal propeptide proteinase or tolloid-
like proteinases [40], depending on the type of collagen. Removal of the propeptides is essential for self-
assembly of the collagen molecules into larger collagen fibrils [41]. The final step in collagen biosynthesis 
includes extracellular covalent cross-linking of collagen molecules by the family of lysyl oxidases. These 
proteins catalyze the condensation of two lysine or hydroxylysine residues, located at the telopeptide 
regions of the collagens [42].  
 
 
 
 
 
 
 
 
Figure 3: Collagen biosynthesis. 1. Procollagens are translated in the rough endoplasmic reticulum. 2. They are 
cotranslationally hydroxylated and 3. selected lysine residues are glycosylated. 4. Procollagens assemble at the 
C-terminus and are covalently connected via disulfide bridges. 5. Procollagen formation is completed and the 
molecule is transported outside the cell. 7. Propeptides are cleaved off. 8. Procollagens assemble into fibrils 
before they are covalently linked via the lysyl oxidase enzyme. Figure is adapted from [1] 
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1.3 POSTTRANSLATIONAL MODIFICATIONS 
 
1.3.1 PROLYL HYDROXYLATION 
 
The most abundant posttranslational modification of collagen is prolyl 4-hydroxylation presenting up to 
38% of the total amino acid composition of collagens [20] and around 4% of all amino acids found in 
animal tissue. The reaction is catalyzed by the tetrameric prolyl 4-hydroxylase with prolyl-procollagen, 2-
oxoglutarate and elemental oxygen as substrates. Fe(II) and ascorbate are essential cofactors for prolyl 
4-hydroxylation. The prolyl 4-hydroxylase is mainly expressed in the lumen of the endoplasmic reticulum 
and is essential for the triple-helical stability of collagen at body temperature of warmbloods. The effect 
of this posttranslational modification becomes evident by comparison of the melting temperature of fully 
hydroxylated collagen type I (Tm = 43°C) with the unhydroxylated form (Tm = 27°C) [22]. Other than 
previously thought, the stabilizing effect does not origin from hydrogen bonding of the hydroxyl group of 
collagen strands but from stereoelectronic effects mediated by the hydroxyl oxygen [43]. 
Prolyl 4-hydroxylase modifies procollagen and around 15 other non-collagenous proteins. While a 
polyproline type II fold is recognized by the prolyl 4-hydroxylase, polyproline alone is not hydroxylated 
by the enzyme [44]. The minimum substrate required for hydroxylation is Gly-X-Pro with proline 
preferred also at position X. Substrate affinity increases with length of the substrate [45]. Mutations in 
the prolyl 4-hydroxylase β-subunit protein disulfide isomerase results in the Cole-Carpenter syndrome 
and is manifested by fragile bones and skull deformations [46]. 
Another form of hydroxylation is conferred by the prolyl 3-hydroxylase. 3-hydroxyproline is much less 
abundant than 4-hydroxyproline and is more frequent in collagen types IV and V than in collagen type I 
or II with 10 - 15 compared to a single 3-hydroxyproline residue per molecule [47]. 3-hydroxyproline 
formation occurs in the X position of Gly-X-4-Hyp [48] and is conferred by one of three isoforms of prolyl 
3-hydroxylases. Different to prolyl 4-hydroxylation, prolyl 3-hydroxylation only affects triple-helical 
stability marginally [49] and must hence possess other functions that remain unknown up to date. 
Mutation in the prolyl 3-hydroxylase gene LEPRE1 results in a disorder resembling lethal osteogenesis 
imperfecta [50]. 
 
1.3.2 LYSYL HYDROXYLATION 
 
Hydroxylysine accounts for about 5‰ of all amino acid residues in whole skin collagen [51]. Equal to the 
previously described prolyl hydroxylases, lysyl hydroxylation requires Fe(II), oxygen, 2-oxoglutarate and 
ascorbate for enzymatic activity. In contrast to the soluble tetrameric prolyl 4-hydroxylases, the lysyl 
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hydroxylases are ER membrane bound and homodimeric. The lysyl hydroxylases only act on native 
collagen chains before triple helix formation. In humans, there exist three isoforms of lysyl hydroxylases 
encoded by the genes PLOD1, PLOD2 and PLOD3. All three isoforms are expressed in the same cells in 
skin, lung, placenta, cartilage, spleen, brain and liver [52] but could not be correlated to expression of a 
specific type of collagen [53] indicating unspecific activity towards various types of collagen. Even though 
many types of collagen can be hydroxylated by all three isoforms, the lysyl hydroxylases contain 
specificity towards the location of the lysines in collagen. PLOD1 hydroxylates preferably lysines located 
in the collagenous domains, while PLOD2 hydroxylates lysine residues in the telopeptide region [54, 55]. 
Such a specificity is not known for PLOD3. 
Lysyl hydroxylation is a prerequisite for two further posttranslational modifications of collagen. Lysine 
residues located in the telopeptide region of collagen are hydroxylated before being covalently 
crosslinked to form intra- and intermolecular bonds by the lysyl oxidase enzymes. Lysine residues mainly 
located in the triple helical region of the collagens are converted to hydroxylysine to serve as acceptor 
for collagen galactosyltransferases. Mutations of any of the three isoforms of lysyl hydroxylases result in 
severe connective tissue disorders.  Mutations in PLOD1 result in Ehlers-Danlos syndrome VI [56], 
mutations in PLOD2 in the Bruck syndrome [57] and mutations in PLOD3 in a connective tissue disorder 
combining symptoms of osteogenesis imperfecta and the Ehlers-Danlos syndrome [58]. 
 
1.3.2 GLYCOSYLATION 
 
Two distinct types of O-glycosylation have been identified in collagen. Hydroxylysine residues in collagen 
can either be monoglycosylated with galactose or diglycosylated with the disaccharide glucosylgalactose 
(Glc(α1-2)Gal(β1-O)Hyl) [59]. Core glycosylation by galactose is transferred by either GLT25D1 or 
GLT25D2 [60]. While GLT25D1 is expressed ubiquitously in all tissues, GLT25D2 expression is limited to 
brain and skeletal muscles. GLT25D1 and GLT25D2 are soluble ER resident enzymes [61] transferring 
galactose from UDP-galactose to collagenous hydroxylysine residues but not to free hydroxylysine [62]. 
The main glucosyltransferase transferring glucose from UDP-glucose to galactosyl-hydroxylysyl residues 
is currently unknown. The multifunctional lysyl hydroxylase enzyme LH3 was shown to transfer glucose 
to galactosylated collagen [63] in low amounts. Glucosylated collagen however also occurs in sponges or 
chicken, which lack a LH3 homologue. It is hence likely that the main collagen glucosyltransferase in 
humans has not yet been identified.  
Collagen glycosylation takes place on nascent collagen strands but not on triple helical collagen [64, 65]. 
The extent of collagen glycosylation differs in tissues and types of collagen. Collagen type IV is believed 
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to be the most glycosylated collagen, whereas fibrillary collagens type I and II carry less collagen 
glycosylation [66].  
Many biological roles have been assigned to collagen glycosylation. Most studies were performed on 
PLOD3 knockout mice and hence leave collagen galactosylation unchanged. Mutation of the 
glucosyltransferase domain of LH3 results in embryonal lethality at E9.5 in transgenic PLOD3 mice 
possibly by altered secretion and assembly of collagen type IV. Fibroblasts extracted from the embryos 
showed aggregated collagen type IV at the ER, which resulted in dilated ER and a condensed Golgi. There 
occured no tetramerization of collagen type IV in KO fibroblasts and secretion was heavily impaired [67]. 
A similar observation was found in C. elegans let-268 knockout worms [68]. Let-268 is a PLOD3 homolog 
(56% sequence identity) and hydroxylates lysine residues. Glycosylation activity however has not been 
identified in let-268 yet. Let-268 knockout worms show deficient collagen type IV secretion and lack a 
basal membrane. All these experiment involving the bifunctional lysyl hydroxylase 3 base on alteration 
of the glucosyltransferase activity. However, mutations in lysyl hydroxylase 3 glycosyltransferase domain 
probably affect its lysyl hydroxylase activity as well. It is hence difficult to assess the role of the collagen 
glucosyltransferase alone. Nevertheless, these results suggest that collagen glycosylation plays a crucial 
role in collagen folding and secretion and further influences supramolecular assembly of collagen IV.  
Other experiments used chemically deglycosylated collagens and mimic the physiological situation only 
up to a limited extent. The urokinase-type plasminogen activator receptor associated protein uPARAP 
internalizes collagen dependent on its fibronectin II domain [69]. The uptake efficiency has been shown 
to be influenced by its lectin domain [70]. uPARAP however does not only mediate uptake of the highly 
glycosylated collagens type IV and V but also of the less glycosylated collagen type I, indicating a minor 
influence of collagen glycosylation [71].  
Several other studies described a steric role for collagen glycosylation. Due to the bulky and polar nature 
of glycans, they can modulate collagen receptor interactions. It was shown that glycosylation disturbs 
melanoma α2β1 and α3β1 integrin interactions with type IV collagen [72]. Another study suggested a 
correlation of collagen type I glycosylation and the valence of crosslinks in fibrillary collagens [73] possibly 
by steric hindrance of the lysyl oxidase enzymes. Hyperglycosylated collagen fibrils from an osteogenesis 
imperfecta mouse model showed an increased fibril diameter [74]. 
Even though collagen glycosylation has been studied for decades in various biological ways, no conserved 
mechanism or function was identified. Therefore, further studies involving the collagen 
galactosyltransferases GLT25D1 and GLT25D2 are inevitable.  
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1.3.3 GLYCATION 
 
Carbohydrates cannot only be covalently bound to collagen via glycosyltransferases, but can also be 
spontaneously attached via non-enzymatic glycosylation (glycation). The sugars glucose, fructose or 
galactose are typically involved in glycation. Glycation efficiency however is ten times higher when 
galactose or fructose is attached in comparison to glucose [75]. Due to the usually low availability and 
the slow reactivity of glucose in blood, glycation in a pathological extent only occurs in diabetic individuals 
with prolonged hyperglycemia or in aged individuals [76]. Non-enzymatic glucose addition to proteins 
occurs spontaneous via formation of a labile Schiff base on available amino groups of lysine residues. 
Over time, the Schiff base rearranges into a more stable ketoamine product and is thus irreversibly linked 
to the protein. Glycated proteins can further undergo various modifications resulting in advanced 
glycation endproducts [77]. Due to the long half-life of collagens, they are the most likely site for glycation 
to occur. After years of elevated blood sugar levels or in aged healthy individuals, these modifications 
accumulate and lead to functional deficits of connective tissue and wound healing [78, 79]. The stiffening 
of the tissue can be explained by crosslinking of advanced glycosylation endproducts of various proteins 
such as collagen or elastin and modification of the molecular properties of membranes and cell surfaces. 
On the surface of many cell types, advanced glycosylation endproducts can be sensed via receptors [80]. 
The receptors for advanced glycosylation endproducts then activate pro-inflammatory pathways via NF-
κB. NF- κB upregulates the receptors and establishes an inflammatory positive feedback cycle that can 
result in organ damage or even organ failure [81]. Many diseases such as atherosclerosis, myocardial 
infarction, diabetic retinopathy, neuropathy and nephropathy are linked to glycated collagens [82-84].    
   
1.3.4 COLLAGEN CROSSLINKS 
 
Most of the biophysical properties of collagen such as the stability and the tenacity arise through the 
exceptional folding of many collagen molecules into collagen fibrils and subsequent crosslinking of these 
fibers. Enzymatic crosslinking occurs at specific lysine or hydroxylysine residues located at the telopeptide 
region of collagen and links an end of a collagen fibril with an intermediate lysine or hydroxylysine residue 
in the triple helical region of another collagen fibril. The aldol condensation that links the fibrils occurs 
spontaneous after extracellular oxidative deamination of the ε-amino group of the lysines to aldehydes 
by a lysyl oxidase enzyme [85]. The aldehydes cannot only react with each other but can also condensate 
with another ε-amino group of a lysine, hydroxylysine or a glycosylated hydroxylysine residue [86] 
resulting in a trivalent crosslink.  
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Lysyl oxidase expression is regulated, among others, by hypoxia inducible factors [87]. Increased lysyl 
oxidase expression was found in hypoxic tissues such as tumors [88], where secreted lysyl oxidase leads 
to tissue remodeling and stiffening of the tumor’s surroundings [89]. This finally results in an increased 
rate of metastasis [90].  
 
1.4 BIOMEDICAL APPLICATION AND PRODUCTION OF RECOMBINANT COLLAGEN 
 
Collagen has a plethora of biomedical applications. The global market size of collagen for regenerative 
and cosmetic medicine including  wound healing and bone graft substitutes in 2014 was estimated at US 
$ 15 billion [91]. Mostly extracted from animal sources, collagen is applied in wound care management 
as skin replacement, in reconstructive surgery as bone substitute, in ophthalmology, in drug delivery and 
for basic matrices in cell culture systems. It is biodegradable and has cell growth stimulating effects. Due 
to a very high similarity of collagens in mammals, bovine and porcine collagen can be applied in humans 
with minimal antigenicity.  Even though collagens from animal origin are categorized as safe, 1 - 3% of 
reported cases showed hypersensitivity towards bovine collagen [92]. Human derived collagens from 
cadavers or placenta are expensive and must be purified from and tested for virus contaminations such 
as hepatitis or HIV. As an alternative, medical applications use recombinant collagens. However, the 
existing expression systems are very expensive, cumbersome due to the necessity of collagens 
posttranslational modifications and are therefore not yet suitable for the large collagen amounts needed 
in biomedical applications. 
 
1.4.1 BIOMEDICAL APPLICATIONS OF COLLAGEN 
 
Patients losing a substantial fraction of their total body surface, through fire or other accidents, face 
several serious threats. Every wound represents a threat for bacterial and viral infections that leads to 
sepsis if not treated appropriately. As intact skin further serves as a barrier for moisture, its damage can 
lead to massive dehydration and shock. Thus, covering and closing of wounds is of utmost importance. A 
widely used method to treat open wounds is a dermal regeneration template (DRT) [93]. It consists of a 
collagen-glycosaminoglycan (GAG) scaffold (98%/2% (w/w)). The collagen scaffold can be engineered 
precisely in order to have a pore size and a degradation rate suitable for fibroblast, macrophage and 
neutrophil migration into the wound site and subsequent replacement of the dermal regeneration 
template by these cells [94].  This results in faster healing, less scarring and immediate physiological 
wound closure.  
 18 
Through crosslinking and variation of the collagen to GAG ratio the degradation rate can precisely be 
defined. This allows incorporation of drugs, such as antibiotics or growth factors, into the DRT matrix in 
order to be topically released over a prolonged period [95-97].  Antibiotic incorporation in the collagen 
scaffold results in higher local concentrations of the antibiotic without having detrimental systemic 
effects as observed when orally administered [98]. Collagen was recently used in combination with lipids 
for the formulation of drug and gene delivering nanoparticles. Due to the well-characterized 
pharmacokinetics, the high biocompatibility and its relatively unelaborate production, collagen 
nanoparticles present promising candidates for future drug delivery systems [99].  
Beauty care represents another important market where collagens have become essential. When 
humans age, collagen type I and III expression in fibroblasts is significantly reduced [100]. This results in 
wrinkles due to the missing collagens in the connective tissue. Wrinkles can be treated with intradermal 
injections of collagen. So far, sources for collagen used in dermal fillers comprise bovine, porcine, human 
cadaver and human fibroblasts from cell culture systems. Even though collagen was the most used dermal 
filler until 2005, hyaluronic acid based fillers gained marked shares and are now used in more than 50% 
of all cosmetic applications in the USA [101] due to improved biocompatibility and longevity compared 
to collagens.  
 
1.4.2 RECOMBINANT PRODUCTION OF COLLAGEN 
 
Native human collagen is heavily modified upon expression in the endoplasmic reticulum. These 
posttranslational modifications, most importantly prolyl hydroxylation, are essential to stabilize the 
collagen triple helix and thereby ensure stability at body temperatures. Hence, collagen expression 
systems must not only express collagen in large amounts but also precisely modify the protein to meet 
the requirements of the application.  
1.4.2.1 COLLAGEN EXPRESSION IN BACTERIA 
Classical biotechnological expression systems for recombinant proteins encompass bacteria such as E. 
coli. Bacterial collagens, originated from Streptococcus pyogenes could be expressed at high levels 
exceeding 19 g/L culture [102-104]. These collagens do not require posttranslational modification and 
self-assemble into a triple helix with Tm of 35 – 39°C.  Although from bacterial origin, these collagens are 
neither immunogenic nor cytotoxic [105], a comprehensive clinical study to evaluate its efficacy and 
safety in humans is however missing.  
Expression of recombinant human collagens in E. coli was only of limited success. Since human collagens 
need prolyl hydroxylation for triple helix stability, the expression system must contain the enzymes for 
prolyl and lysyl hydroxylation. While unhydroxylated collagen type II was expressed at amounts 
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exceeding 10 g/l, coexpression with prolyl 4-hydroxylases decreased expression levels remarkably [106]. 
Human prolyl 4-hydroxylase consists of an α2β2 tetramer in which the α-subunits contain the catalytic 
domain and the β subunits (protein disulfide isomerases) ensure the solubility of the enzyme. Even 
though the human prolyl 4-hydroxylase enzyme could be successfully coexpressed with collagen in 
bacteria, it lacked sufficient activity towards collagenous peptides in order to ensure triple helix 
formation or, due to the coexpression of several cofactors, only yielded low amounts of the recombinant 
collagens [107, 108].  
Another approach to express hydroxylated human collagen involved an engineered E. coli strain with 
increased prolyl aminoacyl-tRNA synthase. Due to the increased availability of prolyl-tRNA, 
hydroxyproline was successfully incorporated in α1(I) collagen fragments by addition of hydroxyproline 
to the hyperosmotic growth medium [109]. Incorporation of hydroxyproline however occurred not only 
at the Y position of the Gly-X-Y triplets, but also at the X position and results in destabilization of the 
collagen triple helix.  
1.4.2.2 COLLAGEN EXPRESSION IN YEAST 
The large majority of studies on heterologous collagen expression were performed in the yeast Pichia 
pastoris. The human prolyl 4-hydroxylase was coexpressed with collagen type I, II and III and contained 
hydroxylation levels comparable to native human collagens [110]. The recombinant human collagens 
folded triple-helically but more than 90% of the collagenous proteins accumulated in the ER [111]. 
Nevertheless, expression levels could be improved by genetic modification of the expression hosts or by 
modification of the collagens. By removal of the N-terminal propeptide, expression levels were increased 
from 15 mg/L to 20 mg/L. Replacement of the C-terminal propeptide with a bacterial trimerization 
domain and the use of codon-optimized, synthetic genes together with improved fermentation control 
parameters enhanced the expression level further to 1.6 g/L [112, 113].  
Biocompatibility of the recombinant human collagen type III derived of P. pastoris was tested in an animal 
model in order to induce platelet aggregation [114]. The recombinant collagen was able to stop bleeding 
in a rabbit spleen six times faster than bovine collagen I. There were no adverse detrimental effects from 
potential contaminants originated from the expression host. Recombinant collagen in form of a collagen 
sponge has proven to induce less inflammatory response compared to animal derived material. 
Recombinant human collagen type I is less porous than animal derived collagen and therefore more 
resistant to bacterial collagenases [115].  
Next to P. pastoris, recombinant human collagens were also expressed in Saccharomyces cerevisiae. By 
coexpression of the chicken prolyl 4-hydroxylase with human procollagen α1(I) and α2(I), triple helical 
collagens with hydroxyproline levels of 82% compared to native human collagen type I were 
accomplished [116]. The collagen consisted however not only of the heterotrimeric α1(I) and α2(I) 
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collagens but to the same amount also of homotrimeric α1(I) collagen.  S. cerevisiae derived type III 
collagen could be triple helically expressed even in absence of both N- and C-terminal propeptides [117]. 
1.4.2.3 COLLAGEN EXPRESSION IN N. TABACUM 
Plants present a cost efficient and easy to manipulate expression system for a variety of small proteins 
up to large antibodies [118, 119]. Prolyl 4-hydroxylase derived from plants was shown to be active 
towards collagen but lacked sequence specificity and hydroxylated the X and Y position of Gly-X-Y triplets 
[120, 121]. Moreover, plants have different N-glycosylation and O-glycosylation patterns that are 
different to those of humans, which are likely to be immunogenic [122]. To circumvent these obstacles, 
human procollagen α1(I) and α2(I) cDNAs were coexpressed together with the cDNAs coding the human 
prolyl 4-hydroxylase and lysyl hydroxylase 3 enzymes. The recombinant collagen was expressed at 1 g/kg 
dry tobacco leaves and was extracted from the vacuoles. The vacuoles represent a closed environment, 
thereby preventing undesirable plant specific N-glycosylation. The collagen was assessed for its 
biocompatibility evaluating binding and proliferation of adult peripheral blood-derived endothelial 
progenitor-like cells [123].  
1.4.2.4 COLLAGEN EXPRESSION IN INSECT CELLS 
Insect cells, such as Spodoptera frugiperda Sf9 cells have become an important expression system for 
transgenes since the development of the baculovirus-insect cell expression system [124].  Even though 
Sf9 cells express endogenous prolyl 4-hydroxylase, its activity was too low to stabilize the recombinant 
collagens. In order to extract stable triple helical recombinant human collagen, the human prolyl 4-
hydroxylase was coexpressed together with human collagen type III. The hydroxyproline content of the 
recombinant human collagen was comparable to native human collagen as assessed by the thermal 
stability and by amino acid analysis. The yield could be improved from 6 mg/L of culture to 40 mg/L trough 
expression in high five cells in suspension.  
1.4.2.5 COLLAGEN EXPRESSION IN MAMMALIAN CELLS AND TRANSGENIC ANIMALS 
Mammalian cell lines harbor a big advantage over all the other expression system regarding collagen 
production due to sufficient endogenous expression of the prolyl 4-hydroxylase. Depending on the cell 
line used, recombinant human collagen type I, II, III and V with hydroxylation and glycosylation patterns 
indistinguishable from native human collagens were produced in amounts ranging from 0.35-2 mg/L in 
HT1080 up to 15 mg/L in the HEK293 cell line [125-127]. The collagens were secreted in the medium and 
allowed relatively unelaborate purification.  
Next to the expression of human collagens type I, II, III and V, the less common collagen type VII (>0.001% 
of total extracted collagen from human skin) was expressed in HEK293 and CHO cells for studies focusing 
on dystrophic epidermolysis bullosa [128, 129]. Recombinant collagen type VII was expressed as triple 
helical fibril at 2 - 5 mg/L. None of the studies analyzed hydroxylation levels but showed triple helix 
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stability by chymotrypsin digestion at 37°C for 3 hours. The collagen was intravenously injected in a 
dystrophic epidermolysis bullosa mouse model and increased life span while reducing clinical symptoms 
[121]. There were no anti-collagen type VII antibodies expressed in mice upon treatment with 
recombinant collagen type VII. 
Due to the high secretory capability of mammary glands, transgenic mice were engineered carrying the 
αS1-casein promoter fused to the human COL1A1 gene. Prolyl- or lysyl hydroxylation has never been 
described for milk proteins. Nevertheless, homotrimeric collagen α1(I)3 was triple helically secreted in 
milk of the transgenic mice and showed around 50% of lysyl and prolyl hydroxylation compared to native 
human collagen. Expression levels reached 8 mg/ml milk [130].  
1.4.2.6 COMPARISON OF RECOMBINANT HUMAN COLLAGEN EXPRESSION SYSTEMS 
In order to produce recombinant human collagen for biomedical applications, expression must be cost 
efficient and highly reproducible, the collagen needs to be biocompatible and contain the appropriate 
posttranslational modifications. Ideally, the posttranslational modifications should be tunable to enable 
a variation of fibril diameter and pore size. This in turn allows selective biodegradability of devices and 
drugs coupled to the devices. The currently available expression systems for recombinant human 
collagens are summarized in table II. 
While recombinant human collagen expression in bacteria is promising concerning yield and cost 
efficiency, its lack of endogenous prolyl hydroxylase and inactivity of the human prolyl 4-hydroxylase 
impeded development of medical devices. Human collagen derived from the yeast strain P. Pastoris and 
from N. tabacum too are inexpensive in production and safe in application as shown in several animal 
models. Expression of recombinant human collagen in mammalian cell lines is possible, but due to 
expensive growth and purification requirements less lucrative than yeast or plant derived products. 
Yeast and plant derived recombinant human collagens are successfully commercialized in two companies. 
FibroGen Inc. distributes pure recombinant human collagen type I and III for medical applications. 
Collplant uses recombinant collagen type I in readily available formulations as bone graft matrix, soft 
tissue repair matrix or wound filler.  
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Table II: Comparison of the available expression systems for recombinant human collagens. 
Expression Host Col. Expressed Yield (mg/l) Advantages Disadvantages 
Bacteria Bac. Col. 19000 Very high yield 
inexpensive 
Elaborate purification, In vivo 
testing missing 
Yeast Human 
Pro α1(I, III) 
1500 High yield 
inexpensive 
Elaborate purification, 
coexpression of P4H 
Plants Human 
Pro α1,2(I) 
1 g/kg dry 
weight 
High yield 
inexpensive 
Possible plant glycosylation 
immunogenic 
Mammalian cell 
culture 
Human 
α1(I,II,III,V, VII) 
0.35 - 5 Secreted col., 
authentic product 
Low yield, expensive 
production 
Transgenic mice Human α1(I) 
 
8000 high yield, 
authentic 
posttranslational 
modifications 
Very expensive development 
costs, low mouse milk 
production 
 
 
1.5 BACTERIAL AND VIRAL COLLAGENS  
1.5.1 BACTERIAL COLLAGENS 
 
The occurrence of collagenous proteins was previously believed to be restricted to multicellular 
organisms. With the increased availability of genomic sequencing data of microorganisms, collagen 
typical (Gly-X-Y)n repeats were identified in genomes of bacteria. Out of 136 analyzed genomes, 25 
bacteria contained 56 proteins with collagenous domains ranging from 7 - 745 Gly-X-Y repeats [131]. All 
of the predicted bacterial collagen-like proteins are flanked by non-collagenous domains and share the 
structural organization of mammal collagens [102]. Different to human collagens, bacterial collagens 
occupy positions X and Y less frequently with proline but often incorporate threonine or charged amino 
acids [131]. This allows triple helical folding of the collagens even in absence of hydroxyproline. Collagens 
in the deep-sea hydrothermal vent worm Riftia pachyptila [132, 133] also incorporate threonine 
predominantly at the X position. These threonine residues are glycosylated and further stabilize the triple 
helix. Even though such glycosyltransferases have not yet been identified in bacteria, occurrence of 
glycosylated collagen in B. anthracis suggests their existence [134].    
Sequence similarity of bacterial compared to mammal collagens infers triple helicity, but only eight 
bacterial collagen-like proteins are confirmed to fold triple helically with Tm’s of 35°C - 40°C [135],[102].  
Unlike in most mammals, where collagens fulfill a structural role in connective tissue, bacterial collagens 
are not part of cell walls but are attached to it. Many, but not all of the bacteria found to express collagen, 
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are pathogenic (e.g. S. pyogenes, B. anthracis, S. enterica). Well-studied members of bacterial collagen-
like proteins are Scl1 and Scl2 that are expressed by Streptococcus pyogenes. The non-collagenous V-
domain of Scl1 was shown to bind to high-density lipoprotein, low-density lipoprotein, factor H, 
complement factor H-related protein 1, fibronectin and laminin [136-139]. The collagenous domain 
further interacts with integrins [140]. Hence, it is believed that the collagenous domain facilitates 
adherence and internalization into host cells, while the non-collagenous V-domain hinders complement 
activation and mediates evasion of the immune system [141]. 
1.5.2 VIRAL COLLAGENS 
Many bacteria are infected with bacteriophages that carry additional genetic information and are 
involved in horizontal gene transfer. Next to virulence factors, many phages encode collagen-like proteins 
as well [142]. Even though there is no proof yet, these collagens are generally annotated as tail fiber 
proteins. So far, only very few collagen-like proteins from virophages have been studied. 
The protein EPclA from the bacteriophage of the pathogenic E. coli strain O157:H7 was recombinantly 
expressed and biochemically and structurally analyzed [143]. The 37 Gly-X-Y repeat containing collagen 
domain is interjacent of two non-collagenous domains.  The protein is trimeric and its collagenous domain 
exhibits a Tm of 42°C. Since the non-collagenous domains of this protein resemble  other non-collagen 
like domains in phage tail fiber proteins, they probably serve a similar cause as bacterial collagen-like 
proteins and enable adherence to their bacterial host [144].   
Another studied collagen-like protein is gp12 from the bacteriophage SPP1 [145]. The 6.6 kDa protein 
contains only eight Gly-X-Y repeats, folds triple helically and exhibits a melting temperature of 37°C to 
43°C. GP12 binds to the major capsid protein gp13. Binding of gp13 in turn stabilizes trimeric gp12 and 
increases its melting temperature by 20°C to 53°C. It is believed that this stabilization ensures the 
cooperative recruitment of freely available gp12 to the bacteriophage capsid when infected cells lyse.   
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1.6 COLLAGENS IN NUCLEOCYTOPLASMIC LARGE DNA VIRUSES (MINI-REVIEW) 
 
The following chapter contains a review with the title 
Collagens in nucleocytoplasmic large DNA viruses  
The manuscript is in preparation and is a collaboration of Stephan Baumann (all in silico data), Nina 
Hochhold (in vitro data, not part of the manuscript yet) and Thierry Hennet. 
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1.6 Collagens in nucleocytoplasmic large DNA viruses 
Nucleocytoplasmic large DNA viruses (NCLDVs) were first described in 1983 with the identification of the 
Paramecium bursaria chlorella virus 1 [146]. The size of their genomes ranges from 100 kb up to 2.5 Mb 
double-stranded DNA, which often encode more than 1’000 genes and thereby exceed genome sizes of 
numerous parasitic bacteria [147]. All NCLDVs share several orthologous genes such as a DNA 
polymerase, RNA polymerase and transcription factors [148]. Some of these virus families are packed in 
giant virus capsules ranging from 700 - 1200 nm in diameter size. These giant viruses are composed of 
members of the Mimiviridae, Megaviridae, Pandoraviridae and Pithoviridae. Even though the 
international committee on taxonomy of viruses did not yet assign a clear classification to the giant 
viruses, a certain relation and a common ancestor can be inferred from gene analysis of the conserved 
viral DNA polymerase [149].  
Mimiviridae and Megaviridae exhibit a close relationship concerning their DNA polymerases, and might 
share a common ancestor from the NCLDV family (Fig. 4). Pandoraviridae have another origin and cluster 
more closely together with coccolithoviruses that are part of the Phycodnaviridae family. Pithovirus 
display the closest similarity to Iridoviridae and Marseilleviridae [150]. All giant viruses show a close 
relationship based on their DNA polymerases, but reveal otherwise a patchy genome acquired from their 
hosts, from other viruses and from bacteria [150].  
Genomic analysis of the well characterized Acanthamoeba polyphaga mimivirus led to the discovery of 
several for virus uncommon proteins such as collagens, a collagen prolyl 4-hydroxylase and a bifunctional 
procollagen lysyl hydroxylase and glycosyltransferase [151-153]. Due to the occurrence of collagens in 
the mimivirus and its close relationship to other giant viruses, we hypothesized collagens being also part 
of other NCLDVs. We analyzed genomic data from more than 60 members of the NCLDVs (Table S1) and 
identified 142 collagen-like protein coding genes containing at least 10 uninterrupted repeats of Gly-X-Y 
(Fig. 4). The occurrence of collage-like genes correlates to the phylogeny as based on the viral DNA 
polymerases (Fig. 4). We found collagen-like genes in all members of the Pandoraviridae, Megaviridae, 
Mimiviridae and Pithoviridae, except in the Cafeteria roenbergensis virus and the Samba virus. The giant 
viruses from these families encode an average of 8.125 (n=16) collagen-like proteins per genome ranging 
up to 16 in the Pithovirus sibericum. We further found two collagen-like genes in the genome of the 
sputnik virophage, two in the genome of the zamilon virophage and three in the organic lake virophage 
(Table III). Sputnik and zamilon parasitize the collagen containing mimivirus. In contrast, the organic lake 
virophage infects the organic lake virus that is deficient in collagen-like genes. 
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Figure 4: Cladogram of the phylogenetic comparison of the viral DNA polymerase from collagen-like protein containing viruses. 
Sequence alignment was produced with Clustal-Omega algorithm. The tree was calculated with maximal likelihood using the 
Mega6 software. Colors of the cladogram branches indicate virus family affiliation, the color of the scientific name indicates host 
specificity.  
Table III: Virophage species that encode collagen-like proteins 
Virus Family Scientific Name Genome 
size / kb 
Collagen-
like genes 
Host Accession- 
number 
Reference 
 
 
Phages 
Sputnik virophage 18.34 2 Mimivirus/ 
Acanthamoeba 
NC_011132.1 [154] 
Sputnik 2 virophage 18.34 2 Mimivirus / 
Acanthamoeba 
JN603369.1 [155] 
Sputnik 3 virophage 18.34 2 Mimivirus / 
Acanthamoeba 
JN603370.1 [156] 
Zamilon 17.28 2 Mimivirus / 
Acanthameba 
NC_022990.1 [157] 
Organic Lake virophage 26.42 3 Algae / 
organ. Lake virus 
HQ704801.1 [158] 
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1.6.1 GENE-STRUCTURE ANALYSIS OF VIRAL COLLAGEN-LIKE PROTEINS 
For further analysis, we focused on the collagen-like proteins from Pandoraviridae, Megaviridae, 
Mimiviridae and Pithoviridae based on the abundance of collagen-like proteins in their genomes. The 
collagenous domains from these giant viruses contain 13 to 390 Gly-X-Y repeats that are either 
uninterrupted or contain 44 or 68 amino acid long interdomains between the collagen domains (Fig 5).  
 
A 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
Figure 5: Structure of viral collagen-like proteins. A) Graphical representation of the collagen-like proteins from mimivirus and 
pandoravirus. Black part: non-collagenous domains, grey part: collagenous domains, blue part: interdomains. B) Sequence of 
two viral collagen-like proteins. Top: mimivirus protein L71, representing a collagen with interdomains. Bottom: Pithovirus 
protein gp240, representing collagen-like protein with uninterrupted collagen domain. Glycine residues are highlighted in red, 
collagenous domain in light grey, glycine-rich c-terminus in dark grey.  
Pithovirus_AZ76_gp240 , Protein ID: YP_009001142.1 
MAVRILSYSPQTGERHISQENNLSRNEGGNNQVPINYRGYTGATGPKGDCGRNGCTGPKGNDGKNGKDGCTGPKGNDGKNGKDGCTGATGPKGDCGKDGCTGPTGPKGDCGKDGCTGPK
GADGKNGKDGCTGPKGDQGLIGCTGLKGDTGPKGDCGKDGCTGPKGADGKDGCTGPTGPKGDCGKDGCTGPKGADGKDGCTGPTGPKGDCGKDGCTGPAGERGPMGSTGPGGPGSCVGT
NRIDLRHPMFLKGCGKCPSLVSSCNESGTLVFTNVALGPTDGSSYIPTSGKISVGTTGIYFISLSVSALPHSCEGLSTTVELCSLTGEERKLVIAQLPLQTIHQNPIYASTTALFPLDP
SIPLEVSFSNKSSAEYDMLHSSLVMFRIY 
Mimivirus_R239, Protein ID: AAV50512.1 
 
MFGNCQKQNCCTQRNNTGICYSVCPPQTVITVPGNVTCNASRIYVNTGRPNNCFGNDGDLYLDTNTNNLYYKRDGVWLLVGNLSGSSGPSGPQGPKGEKGSNGDKGDKGEIGIQGLKGE
SGADADKGDKGDKGDKGSKGTKGENGDKGNKGDKGDPGIKGSKGEKGSKGDKGEKGNKGDKGDIGLKGESGADADKGDKGDKGSKGDKGNKGDIGLKGESGADADKGDKGDKGSKGNKG
DKGTKGESGLIGTKGDKGSKGDEGIKGDKGEAGTSILEGSGVPSPDLGNNGDLYIDGMTGLLYAKINDEWVPVTSIKGDKGSKGDTGLKGESGADADKGEKGDPGNKGDKGSKGDKGDT
GLKGESGADADKGDKGDKGEKGDKGEKGDKGDKGDNGEKGEKGEKGDNGDKGEKGDNGEKGEKGDNGEKGEKGNNGEKGEKGDNGEKGEKGDNGEKGEKGDNGEKGEKGDNGEKGVKGD
PGSNGSKGTKGEKGEKGDKGINGDKGDKGSKGDTGIKGEAGTAANKGDKGSKGDKGDKGSKGDIGISIKGDKGDKGDKGSKGDKGDIGIKGESGLSIKGDKGDKGGKGDKGDLGSKGDI
GLKGDKGDKGDVGLKGDKGDKGDVGSKGDKGDKGSKGDKGSKGDTGSKGDKGDKGSKGDKGDKGDKGSKGDKGDIGSIGPKGEKGEAGSTNSLYIGSAQLGNAGDFNDEVIPVTGIAYI
TAVGAGGSGYSGTTGGYGGGGAGGAFINYPVYVSSSQTYSAHVGFGGAQVAGNSNKGENTTITIGNLVLLAGGGEGGTATTGGTGGLVSINGTQITAGAPGGTSGNSGVSSIYINPLVI
GGAGGGGGSNGTNAGNGGNYAGFTGGIASPGVNGGGGGGASLFSNGFNGETGAPTTDSGTNYGAGGGGGGNGTQGGNGSLGYVRIDFYSAP 
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Pithovirus sibericum and the Pandoraviridae encode only collagen-like proteins with uninterrupted 
collagen domains. The Megaviridae and Mimiviridae express 40 collage-like proteins containing 
uninterrupted collagen domains and 35 collagens with interdomains. The viral collagen-like proteins 
structure resembles the structure of mammalian and bacterial collagens. It contains non-collagenous N- 
and C- terminal domains and the collagenous domain in between. 
1.6.2 NON-COLLAGENOUS DOMAINS 
The viral non-collagenous N-terminal domains range from 25 to 95 amino acids, the non-collagenous C-
terminal domain from 175 to 636 amino acids. For most terminal domains in the viral collagen-like 
proteins, no specific function or structure can be derived from only the amino acid sequence. As 
determined by a Pfam search [159] for all terminal domains, only one known domain was identified. The 
protein L71 from mimivirus that shares a high sequence homology with the protein MG751 from 
Megavirus chiliensis and glt00863 from Moumouvirus goulette encodes a transmembrane exospore 
domain in the non-collagenous C-terminal domain. This domain occurs in many bacteria from the genus 
Bacillus. In Bacillus anthracis, the protein BclB consists of a collagen domain adjacent to a C-terminal 
transmembrane exospore domain and is probably involved in exosporium assembly [160]. In mimivirus, 
L71 was as well identified as a surface protein [152] and a similar function to that of BclB can be 
hypothesized. 
In 50% of all collagen-like proteins found in the Mimiviridae and Megaviridae families, the C-terminal 
non-collagenous domains contained stretches of two to eight repeats of glycine (Fig. 5B). Due to the 
physical properties of glycine, being small and non-polar, it provides conformational flexibility. In 
humans, glycine-rich repeats often occur in transmembrane domains in form of GXXXG motif with X being 
any amino acid [161]. Next to transmembrane proteins, glycine rich repeats occur in structural proteins 
such as keratins (Fig. 6), where the glycine-rich repeats appear in the head and tail region of the proteins 
and, similar to collagen propeptides, aid in keratin multimerization [162, 163]. Whether the glycine rich 
regions serve as anchorage in the mimivirus membrane or serve as nucleation site for collagen 
trimerization cannot be determined from this data.  
 
 
 
 
 
Figure 6: Protein sequence of human keratin type II. Glycine rich head and tail regions are highlighted in grey 
Human keratin type II – P35908 
MSCQISCKSRGRGGGGGGFRGFSSGSAVVSGGSRRSTSSFSCLSRHGGGGGGFGGGGFGSRSLVGLGGTKSISISVAGGGGGFGAAGGFGGRGGGFGGGSSFG
GGSGFSGGGFGGGGFGGGRFGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVKVDPEIQNVKAQEREQIKTLNNKFASFIDKVRFLEQQNQVL
QTKWELLQQMNVGTRPINLEPIFQGYIDSLKRYLDGLTAERTSQNSELNNMQDLVEDYKKKYEDEINKRTAAENDFVTLKKDVDNAYMIKVELQSKVDLLNQE
IEFLKVLYDAEISQIHQSVTDTNVILSMDNSRNLDLDSIIAEVKAQYEEIAQRSKEEAEALYHSKYEELQVTVGRHGDSLKEIKIEISELNRVIQRLQGEIAH
VKKQCKNVQDAIADAEQRGEHALKDARNKLNDLEEALQQAKEDLARLLRDYQELMNVKLALDVEIATYRKLLEGEECRMSGDLSSNVTVSVTSSTISSNVASK
AAFGGSGGRGSSSGGGYSSGSSSYGSGGRQSGSRGGSGGGGSISGGGYGSGGGSGGRYGSGGGSKGGSISGGGYGSGGGKHSSGGGSRGGSSSGGGYGSGGGG
SSSVKGSSGEAFGSSVTFSFR 
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1.6.3 COLLAGENOUS DOMAINS 
The collagenous domains of the viral collagen-like proteins range from an average of 26 G-X-Y repeats in 
the Pandoraviridae up to 400 in the Mimiviridae. Based on the amino acid composition (Tab. IV), there 
are two different families apparent. Pithovirus and the Pandoraviridae contain rather short collagenous 
domains (<60 G-X-Y repeats) and have proline as the most prominent amino acid at the X position. 
Pithovirus incorporates threonine at the Y position of 50% of Gly-X-Y repeats, similar as found in bacterial 
collagen-like proteins or in collagen from the deep sea worm Riftia pachyptila [132, 134]. Pandoraviridae 
exhibit 20 - 27% proline residues at the Y position, similar to human collagens, where hydroxylated 
prolines at the Y position are essential for triple helix stabilization. Viral collagen prolyl hydroxylases have 
been identified in many viral genomes [164] but have not yet been found in Pandoraviridae or in the 
pithovirus. However, prolyl hydroxylases exhibit manifold structures and might be encoded by a not yet 
identified gene [165]. Alternatively, it might not be necessary to stabilize pithovirus collagens by prolyl 
hydroxylation, since its habitat is located above the polar circle in a rather cold climate. An assimilation 
mechanism concerning collagen posttranslational modifications was detected by comparison of cold- and 
warm-water fish. Depending on their habitats, their collagens exhibit different degrees of prolyl 
hydroxylation [166]. Whether or not collagen-like proteins from Pandoraviridae and Pithoviridae are 
hydroxylated and form stable triple helical structures, cannot be answered at this point.  
The second group of viral collagen-like proteins consists of the members of Mimiviridae and Megaviridae. 
The collagenous domains are longer compared to pithovirus and Pandoraviridae ranging from 33 to 395 
G-X-Y repeats. In contrast to mammalian collagens and the collagen-like proteins from pithovirus and 
Pandoraviridae, the Mimiviridae collagen-like proteins contain ~ 60% charged amino acids at the X and 
at the Y position, but barely proline. A similar amino acid frequency is seen in bacteriophages and in 
bacterial collagen-like proteins [167]. These collagens are not stabilized by hydroxyproline but by 
electrostatic interactions. The tripeptides GDK or GEK with oppositional charges adjacent to each other 
were previously studied in the context of triple helix stabilization in host-guest peptides. It was found 
that the triple helical (POG)3-(XYG-XYG)-(POG)3 polypeptides (O=Hydroxyproline) were destabilized by 
10°C by mutation from (POG)3-(PYG-PYG)-(POG)3 to (POG)3-(KYG-KYG)-(POG), but showed an increase in 
triple helix stability via double mutation to (POG)3-(KDG-KDG)-(POG)3   [168]. The stabilizing effect is a 
result from ionic interactions between the collagen strands and additionally influences supramolecular 
assembly in collagen fibrils. In mammalian collagens, charged amino acids make up 20% in average at the 
X position and 12% in the Y position. The frequency however ranges up to 28% at the X position and 27% 
in the Y position in collagen type VII. It is believed that the high content of charged amino acids helps 
stabilizing the collagen domains that are interrupted by non-collagenous domains via electrostatic 
interactions [169]. The stabilizing effect has only been shown in relatively short bacterial collagenous 
peptides, but never in large collagen-like proteins as found in Mimiviridae and Megaviridae. All members 
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of these two families contain, besides collagen-like genes, also collagen-modifying enzymes. The 
mimivirus protein L230 is a bifunctional collagen lysyl hydroxylase and collagen hydroxylysyl 
glucosyltransferase. Modification of the highly abundant lysyine residues by hydroxylation or 
glucosylation could have an influence on triple helix stability, which will have to be studied 
experimentally. 
Based on the findings of multimerization domains in the non-collagenous C-terminal domain as well as 
long collagenous domains with interesting features such as a high percentage of charged residues, a triple 
helical conformation of viral collagen-like proteins can be hypothesized, but still needs to be proven 
experimentally. 
 Three most occurring AA’s at pos. X Three most occurring AA’s at pos. Y 
Name Ø G-X-Y-
repeats/
Protein 
1. 2. 3. 1. 2. 
 
3. 
 
Mimivirus 238 49% D 11% E  9% S 64% K  7% I  6% N 
Mimi. Terra 2 201 46% D 13% E 10% S 62% K  7% I  5% N 
Mimi. Isolate 4 246 45% D 12% E 10% S 65% K  7% I  6% N 
Megav. Chili. 122 43% D 18% E  9% L 49% K  9% I  7% L 
Megav. Courdo 116 41% D 20% E 10% N 49% K  9% I  8% L 
Megav. Terra 1 136 45% D 18% E 10% L 50% K 10% I  6% L 
Moumouvirus  168 52% D 12% E  6% I 53% K 16% L  5% G 
Moumou. Goul. 147 55% D 12% E  7% I 59% K 16% L  5% G 
Hirudovirus 217 46% D 12% E  7% I 64% K  6% I  6% N 
Mamavirus 159 45% D 12% E  8% I 62% K  7% I  6% N 
Megavirus Iba 112 40% D 17% E 10% N 47% K 10% I  8% L 
Pithovirus 52 34% P 16% A  6% V 50% T 12% I  11% D 
Pandora. Inop. 23 55% P 10% A  5% E 27% P 12% A 10% K 
Pandora. Sal. 27 53% P 12% A  5% E 20% P 11% Q 10% A 
Pandora. Dul. 29 58% P  8% A  7% E 23% P 16% K 12% Q 
Sputnik 26 21% D 15% L 11% E 41% K 13% D 13% T 
Zamilon 25 36% D 25% L  8% E 45% K 13% N  8% I 
Human Col. 1-10 266 29% P 13% E  9% L 39% P  8% A  6% Q 
Bacterial  66 30% E 28% P 12% D 22% Q 20% K 18% R 
Table IV: Amino acid composition of the collagenous domains of viral collagen-like proteins. Negatively charged 
amino acids are depicted in blue, positively charged amino acids in red. Data is evaluated from all viral collagen-like 
proteins in a given virus, from human collagens Col1α(I-X) or from 10 different bacterial collagen-like proteins from 
Staphylococcus and Streptococcus species. 
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1.6.4 EVOLUTIONARY ASPECTS OF VIRAL COLLAGEN-LIKE PROTEINS 
There is an ongoing discussion about the evolution of giant viruses and their taxonomy. Phylogenetic 
analysis of several conserved genes such as DNA polymerases, aminoacyl-tRNA synthetases and 
serine/threonine protein kinases showed three distinct origins for the giant virus families. Mimiviridae 
and Megaviridae are distantly related to Phycodnaviridae, Pandoraviridae are related to 
Coccolithoviruses and the Pithovirus is most closely related to Iridoviridae and Marseilleviridae [150]. 
Analysis of 128 mimivirus proteins revealed various origins uniformly distributed over Eucarya and 
Bacteria [170]. Since horizontal gene transfer was involved in the acquisition of many genes of the 
mimivirus, this could also apply for viral collagen-like proteins. Phylogenetic analysis of collagenous 
domains is not feasible due to the conserved G-X-Y repeats. Instead, we identified conserved   
 32 
 
interruptions (interdomains) in the collagenous domains of Megaviridae and Mimiviridae, which can be 
used for phylogenetic analysis (Fig. 7 - 9). 
The interdomains from the viral collagen-like proteins show a high amount of conserved amino acids. 
Several amino acids are 100% conserved even though the collagen-like proteins vary in size of the 
collagenous domains (Fig. 7). There is no relation between collagen length and amount of interdomains. 
Mimivirus R196 for example contains one interdomain, dividing the 395 GXY repeats long collagenous 
domain in 155 and 240 GXY repeats. The shorter mimivirus collagen-like protein L71 contains three 
interdomains, resulting in 10 to 68 GXY repeat containing fragments.  
A basic local alignment search for similarity of the conserved interdomain sequence 
(SSILFGSGIPSPDLGNNGDIYIDTLTGDLYKKINGVWVPQTNIK) (Fig. 8) against the non-redundant protein 
sequences database from NCBI revealed 14 significant hits (E-value < 10-4) from bacterial origin. 
Interestingly, all of the found interdomains are located adjacent to collagenous domains and are part of 
surface proteins (Fig. 9).  
 
 
 
 
Figure 8: Consensus sequence extracted from sequence alignment of interdomains (Fig. 7). Conservation 
quality from 1 – 10 based on biophysical properties of conserved amino acids (polarity, aromaticity, size).  
Figure 7: Sequence alignment of interdomains. Sequences 
were identified and extracted manually from indicated 
collagen-like proteins. Color of the protein corresponds to 
the viral origin of the sequence. Sequences were aligned 
with ClustalW algorithm using the MEGA6 software and 
standard parameters.  
 
YSIRK signal domain/LPXTG anchor domain surface protein [Staphylococcus lugdunensis], WP_050786884 
…ADGKNGQNGRNGRQGTELISGITPPTDSDGLNGDTYIDTNTGDTYKKENGKWVPSGNIKGPKGDKGENGQNGRDGKDVLNGKVDPQSSQGKDGDK
YINTVTGDVFVKSGDNWTNEGNIKGPKGDKGDNGLNGRDGKDVLNGKVNPQPSQGKDGDKYINTVTGDVFVKSGGNWTNEGNIKGPKGDRGERGET
GAKGDKGDNGQNGRDGKDILNGKVNPQPSQGKDGDKYINTVTGDVFVKSGGNWTNEGNIKGPKGDRGERGETGPKGDKGENGTSIGIT…… 
 
Figure 9: Protein sequence extract from one significant hit identified by BLAST-P search for similarity to the 
consensus interdomain identified in Fig. 5. Glycines are depicted in red, collagenous domains are highlighted 
in grey, the interdomains in yellow. 
 
 33 
The bacterial proteins identified by the BLAST search contain 
shorter collagenous domains and resemble the total 
structure of the viral collagen-like proteins only poorly.     
The phylogenetic tree based on the interdomains (Fig. 10) 
can identify the relation of viral collagen-like proteins 
between each other. The tree contains two major branches. 
The top branch predominantly consists of collagen-like 
proteins from Mimiviridae, while the bottom branch contains 
the Megaviridae collagen-like proteins. In between, there are 
sub-branches containing interdomains from moumouvirus 
which cluster partially with Mimiviridae and partially with 
Megaviridae. Many viral collagen-like proteins contain more 
than one interdomain. These interdomains cluster closely 
together (e.g. Mimi_L71 (1) and Mimi_L71 (2), Mimi_L669 (1) 
and Mimi_L669 (2)) and cluster with the interdomains from 
the closest homologues from other viruses (Mimivirus, 
Hirudovirus, Mimivirus Terra2).  The interdomains do not 
only cluster with interdomains from the same proteins, but 
also with proteins found in close genomic proximity of them 
(e.g. Mimi_L668 and Mimi_L669 or Mega_Chi_GP0285 and 
Mega_Chi_GP0286). Duplication of genes is a common 
feature in giant viruses [171]. It can therefore be assumed, 
that the variety of collagen-like proteins was developed 
through gene duplication and subsequent trimming. The 
close homology of the viral collagen-like proteins infers a 
common ancestor for the Mimiviridae and Megaviridae 
collagens-like proteins, which is not identified until today.   
 
 
Figure 10: Phylogenetic tree based on protein sequence 
alignment of interdomains from indicated viral collagen-like 
proteins. The tree was calculated with maximal likelihood and 
tested with 500 repeats of bootstrap replications using the 
Mega6 software 
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1.6.5 HORIZONTAL GENE TRANSFER 
Horizontal gene transfer in bacteria can be achieved by vectors such as bacteriophages or plasmids. 
Several of the giant viruses can be infected by virophages, a phenomenon not observed in other viruses 
[172]. Similar to bacteriophages, virophages hijack the host-virus during replication in virus factories and 
use the host-virus’ replication machinery for self-proliferation [154]. Among the 21 – 26 genes expressed 
by these virophages, we identified two to three collagen-like genes (table III). While Sputnik 1 - 3 and 
Zamilon infect the collagen-like protein containing mimivirus, the organic lake virophage infects the 
organic lake virus that does not encode any collagen-like genes.   
Sputnik virophage protein gp06 and its homolog X812_gp15 from the Zamilon virophage share high 
sequence similarity with mimivirus and mamavirus protein R196 at the C-terminus of the collagen-like 
protein (Fig. 11). Due to the much longer collagen domain in the viral proteins compared to the virophage 
proteins, it is unlikely that the viral collagen-like proteins were acquired via the virophages but rather 
that the virophage collagens originated from its host either partially, or completely with subsequent 
removal of parts of the collagenous domains as also suggested for other non-collagenous proteins [154].  
 
Figure 11: Sequence alignment 
of the C-terminal sequence 
from mimivirus and mamavirus 
proteins R196 and the Sputnik 
protein GP06.  
 
 
 
 
 
 
 
1.6.6 CONCLUSIONS 
We identified 142 collagens in the genomes of 60 analyzed NCLDVs.  By analyzing the amino acid 
composition and the structure of the collagen-like genes, we found different phylogenetic origins of the 
viral collagens. Pandoraviridae and pithovirus contain rather short collagenous domains (15-60 Gly-X-Y 
repeats) with 34 - 58% proline at the X position. While Pandoraviridae occupy the Y position 
predominantly with 20 – 27% proline, pithovirus incorporates threonine in 50% of all Gly-X-Y repeats. In 
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contrast, collagen-like proteins from Mimiviridae and Megaviridae have longer (33 – 395 Gly-X-Y repeats) 
collagenous domains that are interrupted with conserved interdomains in 50% of the collagen-like 
proteins. The collagens from Mimiviridae and Megaviridae further incorporate 47 – 64% oppositely 
charged amino acids at the X and the Y position of Gly-X-Y repeats. A phylogenetic analysis of the 
interdomains revealed a close phylogenetic relationship between the collagen-like proteins from 
Mimiviridae and Megaviridae. The phylogenetic analysis further indicates gene duplication for some of 
the collagens found in Mimiviridae and Megaviridae. Mimivirus isolate 4, which was obtained by 150 
passage cycles of the original Acanthamoeba polyphaga mimivirus contained interdomains identical to 
the interdomains seen in the original mimivirus [173]. This indicates that mutations are not commonly 
incorporated but need at least several hundred passages to occur. While a close relationship for collagen-
like proteins between Mimiviridae and Megaviridae is proven, more data needs to be collected in order 
to produce a reliable phylogenetic analysis also for Pithoviridae and Pandoraviridae. 
Based on the collagen-like amino acid composition, triple helical folding of the collagen-like proteins is 
probable but experimental proof is missing. It can be assumed that collagen-like proteins from 
Mimiviridae and Megaviridae use a mechanism for triple helix stabilization involving electrostatic 
interactions of the collagen molecules. Pandoraviridae might use prolyl hydroxylation for helix 
stabilization, even though such enzymes have not yet been identified in the genomes of these viruses. 
Hydroxylation of prolines stabilizes collagens if incorporated at the Y position but hardly have an effect 
on collagen stability if incorporated at the X position [174, 175]. Pithovirus incorporates threonine at 50% 
at the Y position of all Gly-X-Y repeats resulting in a total content of 8 – 21% threonine in the collagen-
like proteins. A similar pattern of threonine is used in collagens from the deep-sea worm Ryftia pachyptila 
that uses > 16% threonine in order to stabilize collagen. In Ryftia pachyptila, it was shown that 
glycosylation on threonine residues can stabilize the collagen up to a melting temperature of 37°C [132]. 
Further experiments will show whether pithovirus uses a similar strategy to stabilize the collagen-like 
proteins.  
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Table S1: Genomes searched for collagen-like proteins 
Name of the virus Accession number 
Asfarviridae  
African swine fever virus strain Ken05/Tk1 KM111294.1 
African swine fever virus E75  FN557520.1 
African swine fever virus strain BA71V NC_001659.2 
Ascoviridae  
Heliothis virescens ascovirus 3e NC_009233.1 
Trichoplusia ni ascovirus 2c NC_008518.1 
Spodoptera frugiperda ascovirus 1a NC_008361.1 
Iridoviridae  
Aedes taeniorhynchus iridescent virus NC_008187.1 
Invertebrate iridovirus 22 NC_021901.1 
Invertebrate iridovirus 25 NC_023613.1 
Invertebrate iridescent virus 6 NC_003038.1 
Lymphocystis disease virus - isolate China NC_005902.1 
Lymphocystis disease virus 1 NC_001824.1 
Turbot reddish body iridovirus GQ273492.1 
Rock bream iridovirus KC244182.1 
Infectious spleen and kidney necrosis virus NC_003494.1 
Orange spotted grouper iridovirus AY894343.1 
Rock bream iridovirus strain RBIV-KOR-TY1 AY532606.1 
Large yellow croaker iridovirus AY779031.1 
Red sea bream iridovirus AB104413.1 
Andrias davidianus ranavirus isolate 2010SX KF033124.1 
Andrias davidianus ranavirus isolate 1201 KC865735.1 
Common midwife toad ranavirus JQ231222.1 
Tiger frog virus AF389451.1 
European sheatfish virus NC_017940.1 
Ambystoma tigrinum virus KR075886.1 
Singapore grouper iridovirus NC_006549.1 
Chinese giant salamander iridovirus KF512820.1 
European sheatfish virus NC_017940.1 
Ambystoma tigrinum stebbensi virus AY150217.1 
Epizootic haematopoietic necrosis virus NC_028461.1 
Singapore grouper iridovirus NC_006549.1 
Soft-shelled turtle iridovirus  EU627010.1 
Marseilleviridae  
Cannes 8 virus KF261120.1 
Tunisvirus fontaine2 strain U484 KF483846.1 
Marseillevirus NC_013756.1 
Lausannevirus NC_015326.1 
Lausannevirus isolate 7715 HQ113105.1 
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Megaviridae 
Megavirus Chiliensis NC_016072.1 
Megavirus courdo11 JX975216.1 
Megavirus lba isolate LBA111 NC_020232.1 
Megavirus terra1 NC_023640.1 
Mimiviridae  
Sambavirus KF959826.1 
Hirudovirus strain Sangsue KF493731.1 
Moumouvirus goulette KC008572.1 
Acanthamoeba polyphaga moumouvirus NC_020104.1 
Acanthamoeba polyphaga mimivirus AY653733.1 
Acanthamoeba polyphaga mimivirus isolate 4 JN036606.1 
Mimivirus terra2 NC_023639.1 
Cafeteria roenbergensis virus NC_014637.1 
Acanthamoeba castellanii mamavirus JF801956.1 
Molliviridae  
Mollivirus sibericum isolate P1084-T NC_027867.1 
Pandoraviridae  
Pandoravirus Salinus NC_022098.1 
Pandoravirus Dulcis NC_021858.1 
Pandoravirus inopinatum NC_026440.1 
Phycodnaviridae   
Paramecium bursaria Chlorella virus 1 NC_000852.5 
Phaeocystis globosa virus strain 16T NC_021312.1 
Ectocarpus siliculosus virus 1 NC_002687.1 
Ostreococcus lucimarinus virus OlV1 NC_014766.1 
Ostreococcus tauri virus 1 NC_013288.1 
Yellowstone lake phycodnavirus 1 NC_028112.1 
Micromonas sp. RCC1109 virus MpV1 NC_014767.1 
Chrysochromulina ericina virus NC_028094.1 
Aureococcus anophagefferens virus KJ645900.1 
Feldmannia species virus NC_011183.1 
Pithoviridae  
Pithovirus sibericum isolate P1084-T NC_023423.1 
Poxviridae  
Vaccinia virus NC_006998.1 
Parapoxvirus red deer/HL953 strain HL953 NC_025963.1 
Canarypox virus NC_005309.1 
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2. RESULTS 
 
This thesis resulted in two submitted manuscripts. 
Recombinant expression of hydroxylated human collagen in Escherichia Coli 
The manuscript was published in in Journal of applied microbiology and biotechnology in 2013 and was 
done in collaboration with Christoph Rutschmann, Jürg Cabalzar, Kelvin B. Luther and Thierry Hennet. 
Own Contribution:  
Planning and coordination of the study 
Cloning and expression of recombinant human collagen type III 
Coexpression of recombinant human collagen type III with viral prolyl 4-hydroxylase and lysyl 
hydroxylase 
Analysis by circular dichroism 
Writing of the introduction 
 
 
The second manuscript with the title 
Collagen accumulation in osteosarcoma cells lacking GLT25D1 collagen 
galactosyltransferase 
was submitted in February 2016 to the Journal of Cell Science. The manuscript was a collaboration with 
Thierry Hennet. All experiments were performed by myself.  
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2.1.1 ABSTRACT 
 
Collagen is the most abundant protein in the human body and thereby a structural protein 
of considerable biotechnological interest. The complex maturation process of collagen, 
including essential post-translational modifications such as prolyl and lysyl 
hydroxylation, has precluded large-scale production of recombinant collagen featuring 
the biophysical properties of endogenous collagen. The characterization of new prolyl and 
lysyl hydroxylase genes encoded by the giant virus mimivirus reveals a method for 
production of hydroxylated collagen. The coexpression of a human collagen type III 
construct together with mimivirus prolyl- and lysyl hydroxylases in Escherichia coli 
yielded up to 90 mg of hydroxylated collagen per liter culture. The respective levels of 
prolyl and lysyl hydroxylation reaching 25% and 26% were similar to the hydroxylation 
levels of native human collagen type III. The distribution of hydroxyproline and 
hydroxylysine along recombinant collagen was also similar to that of native collagen as 
determined by mass spectrometric analysis of tryptic peptides. The triple helix signature 
of recombinant hydroxylated collagen was confirmed by circular dichroism, which also 
showed that hydroxylation increased the thermal stability of the recombinant collagen 
construct. Recombinant hydroxylated collagen produced in Escherichia coli supported the 
growth of human umbilical endothelial cells, underlining the biocompatibility of the 
recombinant protein as extracellular matrix. The high yield of recombinant protein 
expression and the extensive level of prolyl and lysyl hydroxylation achieved indicate that 
recombinant hydroxylated collagen can be produced at large scale for biomaterials 
engineering in the context of biomedical applications. 
 
Keywords: Protein engineering, post translational modification, hydroxylysine, 
hydroxyproline, virus 
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2.1.2 INTRODUCTION 
 
The structural and functional versatility of collagen in vertebrates makes it a coveted 
protein for tissue and biomaterials engineering. Yet, the considerable size of collagen 
polypeptides and the requirement for post-translational modifications have impeded the 
large-scale production of recombinant collagen featuring the biophysical properties of 
natural collagen. All types of collagen feature a triple helical conformation composed of 
repeats of the G-x-y motif, in which proline and lysine often occur at the x and y positions. 
During translation in the endoplasmic reticulum, selected proline and lysine residues are 
hydroxylated by dedicated hydroxylases, thereby yielding hydroxyproline (Hyp) and 
hydroxylysine (Hyl) (Myllyharju and Kivirikko 2004). The formation of Hyp is essential to 
stabilize the collagen triple helix and confer its thermal stability at body temperature 
(Shoulders and Raines 2009). Lysyl hydroxylation is involved in the formation of covalent 
intra- and inter-molecular crosslinks, contributing to condensation and fibril formation 
(Takaluoma et al. 2007). Hyl also serves as acceptor for the attachment of collagen- 
specific glycans (Schegg et al. 2009). Defects of lysyl hydroxylation lead to diseases such 
as Ehlers-Danlos type-VI (Hyland et al. 1992), Bruck syndrome (van der Slot et al. 2003), 
and skeletal dysplasia (Salo et al. 2008), demonstrating the biological importance of this 
post-translational modification. 
The multimeric organization and limited stability of animal prolyl 4-hydroxylases and 
lysyl hydroxylases make them poor choices for the efficient production of recombinant 
collagen in conventional protein expression systems such as bacteria and yeasts, which 
lack endogenous prolyl and lysyl hydroxylases. Human collagen prolyl 4-hydroxylase has 
been expressed in Escherichia coli (Neubauer et al. 2005; Pinkas et al. 2011), although 
with limited activity towards short collagenous substrates. The coexpression of human 
prolyl 4-hydroxylase  subunits  and collagen  constructs in  the  yeast  Pichia  pastoris has 
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enabled the production of prolyl hydroxylated collagen up to 1.5 g per liter of culture 
(Nokelainen et al. 2001). Dual hydroxylation of proline and lysine has not yet been 
achieved in Pichia pastoris. Coexpression of human prolyl 4-hydroxylase subunits and the 
lysyl hydroxylase LH3 has been described in tobacco plants, in which recombinant human 
collagen type I was expressed at up to 200 mg per kg of fresh leaves (Stein et al. 2009). 
The use of animal cells, such as Sf9 insect cells (Lamberg et al. 1996; Tomita et al. 1995) 
and HEK293 human cells (Fichard et al. 1997) that express prolyl and lysyl hydroxylase 
endogenously, yields recombinant collagen in the g to mg range per liter of culture, 
thereby precluding large-scale applications of the recovered collagen product. 
The description of several aquatic giant viruses belonging to Phycodnaviridae (Van Etten 
2003) and Mimiviridae (Raoult et al. 2004) has shown that collagen-like genes are not 
restricted to metazoans and some prokaryotes. In addition to collagen genes, these 
viruses harbor genes encoding prolyl 4-hydroxylase (Eriksson et al. 1999) and lysyl 
hydroxylase enzymes (Luther et al. 2011). These viral hydroxylases are soluble and active 
when expressed in E. coli, thus opening new possibilities for the production of 
recombinant hydroxylated collagen in bacterial expression systems. So far, human 
collagen type II has been produced at amounts exceeding 10 g per liter (Guo et al. 2010), 
although without post-translational modifications. To circumvent this limitation, we now 
exploit bacterially active prolyl and lysyl hydroxylase enzymes from the giant virus 
mimivirus (Luther et al. 2011) to produce recombinant hydroxylated collagen at high 
yield in E. coli. 
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2.1.3 MATERIALS AND METHODS 
 
Cloning of mimivirus hydroxylase expression vectors - The mimivirus lysyl hydroxylase 
L230 (Luther et al. 2011) and prolyl 4-hydroxylase L593 open reading frames were ampli- 
fied by PCR from mimivirus genomic DNA using primers including XhoI and BamHI sites. 
The primers were 5’-TGACCTCGAGATTAGTAGAACTTATGTAATT-3’ and 5’- 
CAGGGATCCGTCCAATAAAGTGTATCAAC-3’ for L230, 5’-TGACCTCGAGAAAACTG- 
TGACTATCATTACAATA-3’  and  5’-CAGGGATCCATTTTGTGTTAAAAAAATTTTAGG-3’  for 
L593. The resulting amplicons were ligated as XhoI-BamHI fragments into the XhoI- 
BamHI linearized expression vector pET16b, yielding the pET16b-L230 and pET16b- 
L593 vectors. Expression vectors lacking His-tags were prepared by first amplifying the 
L230 and L593 genes using the primers 5’GTCGACGAGCTCACCATGGGCATTAGTAGAAC- 
3’ and 5’-GTAATGACATATGCGCAAGCCCAG-3’ for L230, 5’-ATACCATGGTATTGTCA- 
AAATCTTGTGTGT-3’ and 5’-CAGGGATCCATTTTGTGTTAAAAAAATTTTAGG-3’ for   L593. 
The corresponding amplicons were introduced into pET16b linearized with NcoI-NdeI for 
L230 and with NcoI-BamHI for L593, yielding pET16b-noH-L230 and pET16b-noH-L593. 
The bicistronic vector pET16b-L593/L230 was prepared by inserting the expression 
cassette of the pET16b-L593 as a BglII-HindIII fragment into the BamHI-HindIII- 
linearized pET16b-L230 vector. The bicistronic vector pET16b-noH-L593/L230 featuring 
L230 and L593 without His-tag was prepared in the same way. 
Cloning of collagen expression vectors - A fragment of human collagen type III COL3A1 
cDNA encompassing 1206 bp and lacking propeptide-encoding regions was custom 
synthesized (GenScript, Piscataway, NJ, USA) using codons optimized for bacterial 
expression and including NcoI and BamHI sites at 5’- and 3’-ends (Fig. 1). The pET28a 
expression vector was first digested with NcoI-BamHI, which eliminates the His-tag at the 
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N-terminal site. The resulting hCOL3 segment was inserted as a NcoI-BamHI fragment 
into pET28a, yielding pET28a-hCOL3-His. 
Protein expression in E. coli - The pET16b- and pET28a-based vectors were transformed 
into chemically competent E. coli BL21 (DE3) cells, which were plated on LB-agar plates 
containing 50 μg/ml kanamycin (Sigma-Aldrich) and 100 μg/ml ampicillin (Sigma– 
Aldrich) and incubated overnight at 37°C. Protein expression followed standard protocols 
(Tolia and Joshua-Tor 2006). Briefly, bacteria were grown in liquid cultures at 37°C under 
agitation at 220 rpm until reaching an OD600 value of 0.6. Isopropyl β-D-1- 
thiogalactopyranoside (Sigma-Aldrich) was added to 1 mM to induce expression and the 
cultures were incubated for a further 3 h at 34°C under agitation at 220 rpm. 
Protein purification - Cells were pelleted at 4,000 x g at 4°C for 30 min, resuspended in 3 
ml of 20 mM sodium phosphate, pH 7.4, 100 mM NaCl per gram of E. coli wet weight and 
lysed with 250 μg/ml lysozyme, 4 mg/ml deoxycholic acid under rotation at 4°C for 20 
min. DNAse I (Fluka, Buchs, Switzerland) was added to 20 μg/ml and incubation 
proceeded at room temperature for 30 min. Cell lysates were clarified by centrifugation 
at 12,000 x g for 30 min at 4°C and filtered through 0.22 μm membrane filters (Milipore). 
Imidazole was added to a concentration of 20 mM and His-tagged proteins were purified 
by affinity chromatography on a 1 ml HisTrap FF Ni Sepharose 6 column (GE - Healthcare) 
using an Äkta FPLC system (GE - Healthcare). Elution of His-tagged proteins was 
performed with 500 mM imidazole, 20 mM sodium phosphate, pH 7.4, 100 mM NaCl. His- 
tagged proteins were detected after transfer to nitrocellulose (Highbound ECL, GE- 
Healthcare) using the anti-polyHis HIS-1 monoclonal antibody (Sigma-Aldrich). 
Prolyl and lysyl hydroxylase activity assays - Prolyl and lysyl hydroxylase activities were 
measured as described previously (Luther et al. 2011). Briefly, 5 g His-tag purified L230 
lysyl hydroxylase or L593 prolyl hydroxylase were added to acceptor peptides at 0.5 
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mg/ml in 50 mM Tris-HCl, pH 7.4, 100 μM FeSO4, 1 mM ascorbate, 100 μM DTT, 60 μM 2- 
oxoglutarate and 100 nCi of 2-oxo[14C]glutarate (PerkinElmer Life Sciences) in a total 
volume of 100 μl and incubated at 37°C for 45 min. Released [14C]O2 was captured in a 
filter paper soaked in NCS II Tissue Solubilizer (GE Healthcare) suspended above the 
assay in a sealed 30 ml vial (VWR, Dietikon, Switzerland). Assays were stopped by 
addition of 100 μl ice-cold 1 M KH2PO4 and the filter papers were transferred to 
scintillation vials filled with 10 ml of IRGA-Safe Plus scintillation fluid (PerkinElmer Life 
Sciences). Radioactivity was measured in a Tri-Carb 2900TR scintillation counter 
(PerkinElmer Life Sciences). 
Amino acid analysis - Purified collagens (10 μg) were hydrolyzed in 500 μl of 6 M HCl for 
12 h at 105°C. Hydrolysates were dried down under nitrogen, then washed twice with 500 
μl of H2O and dried down again. Samples were resuspended in 100 μl of H2O and 
derivatized using 9-fluorenylmethoxycarbonyl chloride (FMOC) following the procedure 
of Bank et al. (Bank et al. 1996). Derivatized amino acid samples were analyzed by reverse 
phase HPLC as described in Schegg et al. (Schegg et al. 2009). 
Mass spectrometry - Purified collagens (2 μg) were alkylated with iodoacetamide and 
digested with trypsin (Shevchenko et al. 2006). Briefly, after diluting the sample in 100 
mM ammonium bicarbonate, 0.1% (w/v) RapiGest (Waters, Saint-Quentin, France) and 5 
mM dithiothreitol, the sample was heated for 30 min at 60°C, cooled, and alkylated in 15 
mM iodoacetamide for 30 min in the dark. Proteins were digested with trypsin overnight 
at 37°C and acidified with trifluoroacetic acid to a final concentration of 0.5% prior to 
desalting using a C18 ZipTip (Millipore). Tryptic digests were subjected to reverse phase 
LC-MS/MS analysis using a custom packed 150 mm x 0.075 mm Magic C18- AQ,     3 μm, 
200 Å, column (Bischoff GmbH, Leonberg, Germany) and an Orbitrap Velos mass 
spectrometer (Thermo-scientific).   Peptides were separated with an 80 min gradient  of 
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3% to 97% of a buffer containing 99.8% acetonitrile and 0.2% formic acid. Spectra were 
recorded in the higher energy collisional dissociation mode acquiring 10 MS/MS spectra 
per MS scan with a minimal signal threshold of 2000 counts. Peptides were identified and 
assigned using Matrix Science Mascot version 2.4.1 and verified with the Scaffold version 
4 software (Proteome Software, Inc.) using the X! Tandem search engine. Variable 
modifications included 16 Da on methionine, proline and lysine. 
Circular Dichroism - Proteins were purified by gel filtration using a Superdex 200 10/300 
GL Column (GE – Healthcare). Protein fractions were concentrated in a 10 kDa Spin-XR UF 
500 centrifugal concentrator (Corning) in PBS, pH 7.4, and kept at 4°C at a concentration 
of 0.1 mg/ml prior to analysis. Human collagen type III was purchased from Sigma- 
Aldrich. Measurements were performed with a wavelength between 200 and 250 nm in a 
spectropolarimeter (J-810, Jasco) with a thermostated quartz cell of 1 mm length. 
Thermal stability was analyzed at 221.5 nm under heating at a rate of 0.5°C/min from 4 
°C to 70°C. 
 
Trypsin digestion of collagen - Recombinant hCOL3 (15 g) in PBS pH 7.4 was digested 
with 15 ng trypsin (Roche) for 2 h at temperatures ranging from 10°C to 35°C. Digestions 
were stopped by addition of 2X Laemmli sample buffer and proteins were separated in 
10% SDS-PAGE under reducing conditions. 
Endothelial cell culture - Human umbilical vein endothelial cells (HUVEC) were cultured 
on 0.1% gelatin (Sigma-Aldrich), 0.1% recombinant hydroxylated hCOL3, 0.1% 
recombinant hCOL3 or 0.25% poly-D-lysine in ECM endothelial cell medium (ScienCell, 
Carlsbad, CA) at 37°C in 5% CO2. For immunofluorescence, cells were seeded on glass 
cover slips at 1000 cells / cm2, 13.3 μg coating matrix / cm2 and cultured for 60 h. After 
washing twice with PBS, pH 7.4, cells were fixed with 2% paraformaldehyde for 10 min at 
room temperature, washed twice with 20 mM glycine in PBS and permeabilized with 1 
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mg/ml saponin. Cells were incubated with mouse anti--tubulin SAP.4G5 monoclonal 
antibody (Sigma-Aldrich) diluted 1:200 and labeled with rabbit anti-mouse IgG Alexa-488 
(Life Technology) diluted 1:500 for 30 min. Nuclei were stained with DAPI (Biotium, 
Hayward, CA). Viability was assayed by methylthiazolyldiphenyl tetrazolium reduction 
using standard protocols (Mosmann 1983). 
Sequence data - The L230 and L593 nucleotide sequences reported in this paper have 
the GenBank accession number NC_014649.1. The L230 and L593 protein sequences 
have the UniProtKB/Swiss-Prot accession numbers Q5UQC3 and Q5UP57, respectively. 
The nucleotide sequence of the human hCOL3 construct has the EMBL/EBI accession 
number HG779440. 
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2.1.4 RESULTS 
 
The genome of the giant virus mimivirus contains seven collagen-like genes and open 
reading frames annotated as putative lysyl and prolyl hydroxylases (Raoult et al. 2004). 
We have previously demonstrated that the open reading frame L230 encodes a 
bifunctional collagen lysyl hydroxylase and glucosyltransferase enzyme (Luther et al. 
2011). To confirm the activity of the putative proyl-4-hydroxylase encoded by the open 
reading frame L593, we expressed a His-tagged version of the protein in E. coli. The 669 
bp open reading frame L593 yielded a 26 kDa protein, which could be enriched on Ni2+ 
beads (Fig. 2A). The prolyl hydroxylase activity of the purified L593 protein was assayed 
using acceptor peptides featuring proline in sequences derived from human collagen type 
I, type II, adiponectin and mannose-binding lectin. The L593 protein was active as prolyl 
hydroxylase on the artificial peptide sequence (GPP)7 and on the peptides 
GDRGETGPAGPPGAPGAPGAP and GLRGLQGPPGKLGPPGNPGPS derived respectively 
from collagen type I and mannose binding lectin, each featuring the GPP motif (Fig. 2B). 
By contrast, prolyl hydroxylase activity was minimal on the peptides 
GPMGPSGPAGARGIQGPQGPR and GIPGHPGHNGAPGRDGRDGTP derived respectively 
from collagen type II and adiponectin, which lack the GPP motif (Fig. 2B). The L593 prolyl 
4-hydroxylase was also active on the non-collagenous peptide (SPAP)5 derived from 
proline-rich mimivirus proteins, thus indicating that L593 was not strictly specific 
towards G-x-y repeats (Fig. 2B). 
To assess the ability of mimivirus L230 lysyl hydroxylase and L593 prolyl 4-hydroxylase 
to modify collagen fragments produced in E. coli, we coexpressed the two mimivirus 
hydroxylases together with a 38 kDa fragment of human COL3A1 collagen type III. To this 
end, the mimivirus L230 and L593 open reading frames were expressed bicistronically 
under kanamycin selection and the human hCOL3 fragment on a separate plasmid under 
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ampicillin selection. The hCOL3 protein included 119 G-x-y repeats flanked by the N- and 
C-telopeptide sequences but lacking the N- and C-propeptide sequences (Fig. 1). The co- 
transformation of E. coli with the hydroxylase-containing plasmid and the human hCOL3 
construct yielded expression of the three His-tagged target proteins at the expected 
molecular masses of 101 kDa, 37 kDa, and 26 kDa corresponding to L230, hCOL3, and 
L593, respectively (Fig. 3A). As a next step, the L230 and L593 hydroxylases were 
expressed without His-tags to enable the single enrichment of the hCOL3 protein from E. 
coli cell lysates. The expression of hCOL3 alone or together with L230 and L593 
hydroxylases showed that the collagen fragment reached similar expression levels. After 
purification by Ni2+ affinity chromatography, 90 mg of collagen protein per liter of 
bacterial culture were routinely obtained. Of note, the coexpression with L230 and L593 
hydroxylases produced a smear above the expected hCOL3 band, suggestive of a larger 
protein size or a decreased migration in polyacrylamide gels (Fig. 3B). This smear may 
also reflect heterogeneity at the level of prolyl- and lysyl hydroxylation of the recombinant 
protein. 
The level of prolyl- and lysyl hydroxylation of the hCOL3 protein achieved by co- 
expression with L230 and L593 hydroxylases was determined by amino acid analysis. 
Native human collagen type III and the recombinant His-tagged hCOL3 protein expressed 
with or without L230 and L593 hydroxylases were hydrolyzed under acidic conditions, 
and derivatized with FMOC. The separation of FMOC-labeled amino acids by HPLC 
analysis showed that 54% of proline residues and 47% of lysine residues were 
hydroxylated in native human collagen type III (Fig. 4A). By comparison, the levels of 
prolyl and lysyl hydroxylation reached respectively 25% and 26% in the human hCOL3 
protein coexpressed with the L593 and L230 hydroxylases (Fig. 4B). In the absence of 
L593 and L230 hydroxylases no prolyl and no lysyl hydroxylation were observed in   the 
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recombinant hCOL3 protein (Fig. 4C). The efficient hydroxylation of recombinant hCOL3 
indicates that substrates and co-factors required by the L593 and L230 hydroxylases are 
present in sufficient amounts in E. coli cultured in standard LB medium. 
The distribution of Hyp and Hyl residues across the recombinant hCOL3 protein was 
investigated by mass spectrometry. The analysis of tryptic digested hCOL3 covered 92% 
of the sequence including 84 of 87 proline residues and all 12 lysine residues of the hCOL3 
protein. The analysis of three different batches of recombinant hCOL3 protein revealed 
that between 66% and 83% of covered proline residues were hydroxylated (Table 1). For 
lysine residues, between 55% and 80% were detected as hydroxylated (Table 1). The 
assembly of tryptic peptides showed that hydroxylation was evenly distributed across the 
hCOL3 protein (Fig. 5A, Fig. S1). The mimivirus prolyl 4-hydroxylase did not appear to 
prefer proline residues at either the x or y position of the G-x-y motif. Several G-P-P motifs 
even included Hyp residues at both x and y positions. The recombinant hCOL3 protein 
included 12 lysine residues, of which 6 to 8 were hydroxylated (Fig. 5A). As observed for 
Hyp, the positions of Hyl residues within the G-x-y motif indicated that the mimivirus lysyl 
hydroxylase enzyme efficiently hydroxylated residues at both x and y positions. We 
compared the pattern of proline and lysine hydroxylation between native human collagen 
type III and the recombinant hCOL3 protein expressed in E. coli. The analysis revealed a 
similar distribution of hydroxylated amino acids across both polypeptide sequences (Fig. 
5B). Overall, more Hyp residues were identified in the recombinant hCOL3 protein than 
in native collagen type III, although differences were minimal across the sequence regions 
surveyed. These sequences included only three lysine residues, only one of which was 
found to be hydroxylated in native collagen type III. By contrast, these three lysine 
residues were hydroxylated in the recombinant hCOL3 protein (Fig. 5B, Fig. S1). Hyl 
residues on recombinant hCOL3 were not further modified, for instance, by glycosylation. 
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We recently showed that the L230 protein is a bifunctional enzyme including both lysyl 
hydroxylase and Hyl glucosyltransferase domains (Luther et al. 2011). Whereas L230 
efficiently converted lysine to Hyl, the enzyme failed to glycosylate the resulting Hyl 
residues on recombinant collagen, suggesting that the substrate UDP-Glc was not 
accessible in amounts sufficient to enable the L230-mediated glycosylation of 
recombinant collagen in E. coli. 
The triple helical conformation and the thermal stability of the recombinant hCOL3 
protein were investigated by circular dichroism. The ellipticity spectra obtained for non- 
hydroxylated and hydroxylated hCOL3 proteins showed the typical shape for triple helical 
collagen with a maximum peak around 221 nm and a negative peak below 200 nm (Fig. 
6A). The changes in ellipticity at 221.5 nm during heating were monitored for non- 
hydroxylated and hydroxylated hCOL3 proteins to assess the thermal stability of both 
constructs. The triple helical conformation of the non-hydroxylated hCOL3 protein was 
unstable and showed an approximate 50% loss of ellipticity by 19.5°C (Fig. 6B). Since non- 
hydroxylated hCOL3 did not yield constant ellipticity values at low temperatures, 19.5°C 
however  cannot  be  defined  as  true Tm value. By  contrast,  the hydroxylated hCOL3 
protein showed a 50% loss of ellipticity by 24.3°C, indicating that hydroxylation increased 
the thermal stability of the construct (Fig. 6B). We also compared the degree of triple 
helical conformation in non-hydroxylated and hydroxylated hCOL3 by digestion with 
trypsin, which cleaves denatured collagen but not triple helical collagen (Bruckner and 
Prockop 1981). Hydroxylated hCOL3 was resistant to trypsin up to 30°C whereas non- 
hydroxylated hCOL3 was mostly degraded by 30°C (Fig. 6C). Both forms of hCOL3 were 
completely degraded by 35°C, which confirmed their low thermal stability below 37°C. 
The biocompatibility of hydroxylated and non-hydroxylated recombinant hCOL3 
produced in E. coli was assessed by using the protein as a matrix supporting the  growth 
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of HUVEC. These cells prefer to grow on extracellular matrix proteins such as fibronectin 
and collagen (Smeets et al. 1992). The growth of HUVEC was compared between poly-D- 
lysine, bovine gelatin, recombinant non-hydroxylated hCOL3 and recombinant 
hydroxylated hCOL3 used as support. Cell morphology was examined by 
immunofluorescent staining of microtubules. When cultured on recombinant 
hydroxylated and non-hydroxylated hCOL3, cell viability after 60 h culture reached 
respectively 64% and 49% of the viability observed when cells grew on 0.1% gelatin. As 
expected, viability was lowest when cells were cultured on poly-D-lysine (Fig. 7A). Cell 
morphology assessed by staining of microtubules showed that cells were evenly spread 
and tightly attached to the gelatin and hydroxylated hCOL3 matrices as indicated by the 
large number of processes (Fig. 7B). By contrast, the amount of rounded cells was elevated 
when non-hydroxylated hCOL3 was applied as matrix and few cells were visible when 
cultured on poly-D-lysine (Fig. 7B). The compatibility of hydroxylated hCOL3 as support 
for the growth of HUVEC demonstrated that the recombinant protein was suitable for 
biological applications such as matrix-assisted cell proliferation and adhesion. 
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2.1.5 DISCUSSION 
 
The production of recombinant collagen requires post-translational modifications which 
are lacking in bacterial and yeast expression systems. In the present study we show that 
the prolyl hydroxylase L593 and the lysyl hydroxylase L230 from the giant virus 
mimivirus can be expressed as active enzymes in E. coli without any toxicity for the host 
cells. The coexpression of these two mimivirus hydroxylases with human collagen 
constructs enabled the efficient hydroxylation of proline and lysine residues across 
collagen requiring neither supplementation of co-factors, nor increased oxygen partial 
pressure. 
To date, typical cost-effective and high-yield expression systems like yeasts and bacteria 
have not allowed the production of both prolyl and lysyl hydroxylated collagen because 
of the low activity of animal hydroxylases introduced in these hosts. The best results were 
obtained in the yeast Pichia pastoris expressing human prolyl 4-hydroxylase, which 
enabled 44% hydroxylation of proline residues on recombinant human collagen type III 
(Vuorela et al. 1997). However, efficient lysyl hydroxylation of collagen has not been 
achieved in Pichia pastoris so far. The degree of collagen hydroxylation is also a limiting 
factor for expression systems based on animal cells. Accordingly, the endogenous prolyl 
4-hydroxylase and lysyl hydroxylase activities of insect cells did not yield efficient 
modification of recombinantly expressed collagen without co-transfection with human 
prolyl 4-hydroxylase subunits (Lamberg et al. 1996). 
The expression of prolyl and lysyl hydroxylase enzymes derived from the giant virus 
mimivirus yielded degrees of hydroxylation for recombinantly expressed collagen close 
to those of native collagen type III. The roles of the prolyl hydroxylase L593 and lysyl 
hydroxylase L230 in mimivirus biology are unknown but the presence of seven collagen 
genes in the mimivirus genome  (Raoult et al. 2004) suggests that  L593 and L230     are 
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involved in the hydroxylation of mimivirus collagen. Indeed, we have previously shown 
that the mimivirus collagen-like protein L71 is hydroxylated and glycosylated in vitro by 
the L230 enzyme (17). Structurally related proteins are also found in related giant viruses, 
such as megavirus (Arslan et al. 2011) and moumouvirus (Yoosuf et al. 2012), which also 
include collagen genes in their genome. Considering their stability and activity when 
expressed in E. coli, proteins from giant viruses may represent a valuable source of 
enzymes for biotechnological applications, as shown here for the production of 
hydroxylated recombinant collagen. 
The distribution of Hyp and Hyl residues on recombinant hCOL3 showed that mimivirus 
hydroxylases were able to hydroxylate proline and lysine in various sequence contexts. 
The pattern of prolyl hydroxylation showed that proline at either position x or y of the 
motif G-x-y could be efficiently hydroxylated. Studies performed on synthetic peptides 
containing Hyp at positions x or y or both demonstrated that Hyp at position y strongly 
increases thermal stability (Jiravanichanun et al. 2006) whereas Hyp at position x 
destabilizes the triple helical conformation in Gly-Hyp-y repeats (Inouye et al. 1982). The 
presence of Hyp at both positions x and y by contrast, further stabilized the triple helical 
conformation of the peptides (Berisio et al. 2004). The detection of several Hyp residues 
at position x on various types of collagen makes it difficult to predict the positional impact 
of Hyp on the thermal stability of more complex polypeptides (Bann and Bachinger 2000; 
Buechter et al. 2003; Song and Mechref 2013). Although early work demonstrated that 
Hyp occurs exclusively at position y (Fietzek and Rauterberg 1975), recent studies 
showed that Hyp also occurs at position x in fibrillar collagens (Song and Mechref 2013; 
Weis et al. 2010). 
In animal cells the C-propeptide domain of collagen is important for the initiation of triple 
helix formation in the endoplasmic reticulum and contributes to the solubility of the 
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molecules along the secretory pathway (Boudko et al. 2012). The addition of trimerization 
domains to short collagen constructs, such as the bacteriophage T4 foldon domain at the 
C-terminus of a [GPP]10 sequence, was reported to dramatically increase the thermal 
stability of the collagen construct (Boudko et al. 2002). Although advantageous in 
accelerating triple helix formation, the addition of propeptides in recombinant collagen 
constructs expressed in E. coli or Pichia pastoris later requires their removal for formation 
of fibrillar structures. This procedure is usually performed by pepsin digestion, which 
leaves the triple helical domain intact but also removes the short telopeptides sequences 
required for the registration of collagen molecules in order to form fibrils (Capaldi and 
Chapman 1982). Therefore, we chose to produce an hCOL3 construct devoid of 
propeptides but including the telopeptides necessary for fibrillogenesis. The absence of 
propeptides did not affect the solubility of the recombinant hCOL3 protein and simplified 
down-stream processing by avoiding protease digestion and removal from purified 
collagen. 
The simplicity of this mimivirus hydroxylase expression system enables the efficient post- 
translational hydroxylation of proteins containing collagen domains. In addition to the 
family of true collagens, several collagenous proteins like adiponectin, mannose-binding 
lectin and the surfactant proteins A and D can now be produced as hydroxylated proteins 
in E. coli. The high yield of bacterial expression combined with a high degree of prolyl and 
lysyl hydroxylation provides the framework for the large-scale production of 
recombinant collagens for human applications, in which animal collagens represent 
significant risks for allergic reactions and zoonotic disease transmission. 
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FIGURE LEGENDS 
 
FIGURE 1. DNA and protein sequence of synthetic human hCOL3 construct. The top 
panel shows the codon optimized DNA sequence of the truncated human hCOL3 cDNA 
construct flanked by a 5’ NcoI site and 3’ BamHI site (underlined). The ATG and TGA 
stop codon are bold and shaded. The sequence encoding the His-tag preceding the stop 
codon is dash-underlined. The bottom panel shows the amino acid sequence of the 
truncated human hCOL3 protein. The Gly-x-y collagen domain is shaded. 
 
 
FIGURE 2. Bacterial expression and characterization of mimivirus L593. A, SDS-PAGE of 
mimivirus L593 expressed in E. coli shown as cell lysate (L) and after Ni2+-affinity 
purification (P), either after staining with Coomassie blue R-250 or after Western blotting 
with anti-His6 antibody. B, Prolyl hydroxylase activity of purified mimivirus L593 assayed 
on the peptide acceptors [SPAP]5 (1), [GPP]7 (2), GDRGETGPAGPPGAPGAPGAP from 
human collagen type I (3), GPMGPSGPAGARGIQGPQGPR from human collagen type II (4), 
GLRGLQGPPGKLGPPGNPGPS from human mannose-binding lectin (5), 
GIPGHPGHNGAPGRDGRDGTP from human adiponectin (6). Open bars show prolyl 
hydroxylase activity measured without peptide acceptor and black bars with peptide 
acceptors. Stars above bars indicate statistically significant activity using two-tailed 
paired t-test (p<0.01). 
 
 
FIGURE 3. Coexpression of His-tagged mimivirus hydroxylases L593 and L230 with His- 
tagged human hCOL3 fragment. A, SDS-PAGE of mimivirus L593, mimivirus L230, and 
human hCOL3 construct expressed in E. coli shown as cell lysate (L) and after Ni2+- 
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affinity purification (P), either after staining with Coomassie blue R-250 or after 
Western blotting with anti-His6 antibody. B, SDS-PAGE of His-tagged human hCOL3 
construct expressed alone (-) or with L593 and L230 hydroxylases (+), shown after 
staining with Coomassie blue R-250 or after Western blotting with anti-His6 antibody. 
 
 
FIGURE 4. Amino acid analysis of native and recombinant human hCOL3. Purified hCOL3 
proteins were acid hydrolyzed and the resulting amino acids labeled with FMOC, and 
separated by HPLC. The positions of amino acids are indicated by the single letter code. 
The positions of hydroxyproline (Hyp) and hydroxylysine (Hyl) are marked by arrows. 
A, native human COL3A1; B, recombinant hCOL3 construct coexpressed with mimivirus 
L593 and L230 hydroxylases; C, recombinant hCOL3 construct expressed alone. 
 
 
FIGURE 5. Distribution of Hyp and Hyl on recombinant human hCOL3. A, The occurrence 
of hydroxylated residues was determined by mass spectrometric analysis of tryptic 
digests from recombinant human hCOL3 protein. Grayed sequences represent portions 
of the sequences not covered in the analysis. Proline (P) and lysine (K) residues identified 
as hydroxylated are shaded. B, Comparison of Hyp and Hyl distribution on stretches of 
native human COL3A1 (nat) and recombinant human hCOL3 (rec) produced in E. coli. 
Proline (P) and lysine (K) residues identified as hydroxylated are shaded. 
 
 
FIGURE 6. Circular dichroism of recombinant human hCOL3. A, Samples of purified 
hydroxylated (left panel) and non-hydroxylated recombinant hCOL3 protein (right 
panel) protein at 0.1 mg/ml were scanned between 200 and 250 nm in a 
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spectropolarimeter. B, Thermal transitions of hydroxylated (left panel) and non- 
hydroxylated recombinant hCOL3 protein (right panel) in PBS, pH 7.4 measured at 
221.5 nm under a heating rate of 0.5°C/min from 4°C to 70°C. The Tm values were 
determined at the midpoints of the sigmoid curves. C, Trypsin digestion of hydroxylated 
(left panel) and non-hydroxylated recombinant hCOL3 protein (right panel); the 
arrowhead at the right shows the position of the hCOL3 protein. 
 
 
FIGURE 7. Growth of HUVEC on recombinant human hCOL3 matrix. A, The viability of 
HUVEC seeded at 1000 cells per cm2 was determined by reduction of 
methylthiazolyldiphenyl tetrazolium to formazan after 60 h incubation at 37°C on the 
matrices: 0.1% gelatin, 0.1% hydroxylated recombinant human hCOL3 (hCOL3-OH), 
0.1% non-hydroxylated recombinant human hCOL3 (hCOL3), and 0.25% poly-D-lysine 
(PDL). Cell viability is expressed relatively to the values obtained for the positive control, 
0.1% gelatin. Data show the mean and standard error of the mean of three experiments. 
All conditions tested were significantly different (p-value < 0.05) to cell viability on PDL 
as determined by one-way ANOVA test with Bonferroni multiple comparison. B, 
Immunofluorescence microtubule (green) and DNA (blue) staining of HUVEC grown on 
0.1% gelatin, 0.1% hydroxylated recombinant human hCOL3 (hCOL3- OH), 0.1% non-
hydroxylated recombinant human hCOL3 (hCOL3), and 0.25% poly-D- lysine (PDL).
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Table 1. Hydroxylation efficiency of recombinant hCOL3 protein. Tryptic digests were 
analyzed for hydroxylation of proline (Pro) and lysine (Lys) by mass spectrometry. 
 
 
  
AAa 
Coverage 
[%] 
 
Pro 
 
Hyp 
Hyp/Pro 
[%] 
 
Lys 
 
Hyl 
Hyl/Lys 
[%] 
hCOL3 401  87   12   
Batch 1 346 86 80 56 70 11 6 55 
Batch 2 343 86 80 53 66 11 6 55 
Batch 3 291 73 63 52 83 10 8 80 
Combinationb 368 92 84 59 70 12 9 75 
 
 
a covered amino acid length 
 
b combined assembly of tryptic peptides from batches 1 to 
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2.2.1 ABSTRACT 
 
Collagen is post-translationally modified by prolyl and lysyl hydroxylation and subsequently by 
glycosylation of hydroxylysine. Despite the widespread occurrence of the glycan structure Glc(α1- 2)Gal 
linked to hydroxylysine in animals, the functional significance of collagen glycosylation remains elusive. 
To address the role glycosylation in collagen expression, folding and secretion, we used the CRISPR/Cas9 
system to inactivate the collagen galactosyltransferase GLT25D1 and GLT25D2 genes in osteosarcoma 
cells. Loss of GLT25D1 lead to increased expression and intracellular accumulation of collagen type I 
whereas loss of GLT25D2 had no effect on collagen secretion. Inactivation of the GLT25D1 gene resulted 
in a compensatory induction of GLT25D2 expression. Loss of GLT25D1 decreased collagen glycosylation 
by up to 60% but did not alter collagen folding and thermal stability. Whereas cells harboring individually 
inactivated GLT25D1 and GLT25D2 genes could be recovered and maintained in culture, cell clone with 
simultaneously inactive GLT25D1 and GLT25D2 genes could be not grown and studied, suggesting that 
a complete loss of collagen glycosylation impairs osteosarcoma cell proliferation and viability. 
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2.2.2 INTRODUCTION 
 
Collagens, the most abundant animal proteins, are essential components of the extracellular matrix of 
various tissues and organs. Collagens are mainly located in connective tissue and regulate a variety of 
biological processes such as cell attachment, migration, proliferation, and differentiation [1]. 
Collagens feature specific domains composed of Gly-X-Y repeats with proline and lysine often occupying 
the X and Y positions. Nascent procollagen chains are modified co-translationally by prolyl 4-
hydroxylation [2], prolyl 3-hydroxylation [3], lysyl hydroxylation [4], and by glycosylation of selected 
hydroxylysine (Hyl) residues [5]. Collagen modifications take place in the endoplasmic reticulum before 
completion of triple helix assembly [6]. The importance of collagen hydroxylation is underlined by 
various diseases linked to defective collagen modifications. For example, prolyl 3-hydroxylase 1 
deficiency causes osteogenesis imperfecta with severe skeletal deformation [7], mutation in the lysyl 
hydroxylase 1 PLOD1 gene causes Ehlers-Danlos syndrome type VI [8]. 
Mutations in the lysyl hydroxylase 2 PLOD2 gene cause Bruck syndrome [9] and mutations in the lysyl 
hydroxylase 3 PLOD3 gene cause connective tissue defects typical of collagen disorders [10]. A recently 
identified mutation of the prolyl 4-hydroxylase β-subunit protein disulfide isomerase causes Cole-
Carpenter syndrome [11]. By contrast, the biological significance of collagen glycosylation remains 
elusive as no disease has been associated with the process and no model organism harboring defective 
collagen glycosylation has been described to date. 
The GLT25D1 and GLT25D2 genes encode Hyl-specific galactosyltransferase enzymes, which initiate 
collagen glycosylation [12,13]. The gene encoding the α1-2 glucosyltransferase enzyme, which adds Glc 
to galactose (Gal), has not been identified yet, although the lysyl hydroxylase 3 enzyme has been 
claimed to also act as a collagen glucosyltransferase [14].The resulting Glc(α1-2)Gal disaccharide is 
strongly conserved in all animal collagens, from sponges up to mammals [14-17]. Whereas GLT25D1 is 
broadly expressed across tissues, GLT25D2 is mainly expressed in brain tissue and at low levels in 
skeletal muscle [18]. The GLT25D1 and GLT25D2 galactosyltransferases share identical enzymatic 
activities and substrate specificities, as they are able to glycosylate various types of collagen to similar 
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levels [18]. 
Despite the recent identification of the GLT25D1 and GLT25D2 galactosyltransferases, little is known 
about the functional role of collagen glycosylation. Glycosylation has been shown to affect the binding 
of the urokinase-type plasminogen activator receptor associated protein (uPARAP) to collagen type IV, 
thereby implying collagen glycosylation in receptor-mediated matrix remodeling [19]. Also integrins 
appear to be sensitive to collagen glycosylation, as decreased integrin-mediated cell adhesion was 
measured on galactosylated collagen peptides compared with unmodified peptides [20,21]. 
Glycosylation of Hyl is notably not confined to collagens. The collagen domains of multimeric proteins 
such as adiponectin and mannose-binding lectin also carry glycosylated Hyl, where lysyl hydroxylation 
and glycosylation influence protein oligomerization [22-24]. 
Considering the possible functional involvement of glycosylation in collagen folding and intracellular 
trafficking, we investigated collagen properties after inactivation of the GLT25D1 and GLT25D2 
galactosyltransferase genes in osteosarcoma cells, which produce large amounts of fibrillar collagens, 
including collagen type I, V and minor amounts of collagen type III. 
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2.2.3 MATERIALS AND METHODS 
 
Cell lines and culture conditions – SaOS-2 cells (ATCC:HTB-85), U2OS cells (ATCC:HTB-96) and MG63 
cells (ATCC:CRL-1427) were provided by Dr. Roman Muff (Sarkomzentrum Zürich, University of Zurich). 
Cells were grown in McCoy’s 5A (Modified) medium (Thermo Fisher, Waltham, MA) containing 15% 
fetal bovine serum (Biochrom, Berlin, Germany) at 37°C in 5% CO2. 
Cloning and transfection of CRISPR/Cas9 vectors – The guide RNA (gRNA) sequences for GLT25D1 exon 
2 (fw: 5’-CACCGGAAGAGTTTGTACCATTCCG-3’, rev: 5’- AAACCGGAATGGTACAAACTCTTC-3’), for 
GLT25D2 exon 3 (fw: 5’-CACCGCCATGTGATGAAACTACGAC-3’, rev: 5’-AAACGTCGTAGTTTCATCACAT-
GGC-3’) and for the control construct (fw: 5’- CACCGGAAGAGTTTGTACCTTTCCG-3’, rev: 5’- 
AAACCGGAAAGGTACAAACTCTTC-3’) were ligated into the BbsI sites of pSpCas9(BB) (gift from Dr. Feng 
Zhang, Addgene plasmid # 48139). Osteosarcoma cells were transfected using the AMAXA nucleofector 
kit (Lonza, Basel, Switzerland) according to the manufacturer protocol. Cells were selected for positive 
transfection with 0.5 µg/ml of puromycin (Santa Cruz Biotechnology Inc, Dallas, TX). Single clones were 
isolated and analyzed for mutations in the targeted genes using the Surveyor Nuclease assay 
(Integrated DNA Technologies, Coralville, IA) [25] and the primers 5’-
GGAGAAGTGTCCTGTCCAGGGATAC-3’, 5’- ACAGGGAACGGCTTGGGCAAAGGTC-3’ for GLT25D1 exon 2 
and 5’-CCCTGATGAAATTGGACCAAAGC-3’, 5’-TGCCTTTCTTAAAAAGTGGGGG-3’ for GLT25D2 exon 3. 
Mutations were confirmed by Sanger sequencing (Microsynth, Balgach, Switzerland). 
Cloning and transfection of GLT25D1 overexpression vector – GLT25D1 cDNA was cloned from the 
pFastBacI baculovirus transfer vector from [18] in pcDNA3.1(+) (Thermo Fisher) using the NotI and XbaI 
restriction sites. SaOS-2 cells were transfected using AMAXA nucleofector kit (Lonza). Cells were 
selected 48 h after positive transfection using 2.5 µg/ml of geneticin (Thermo Fisher) for 10 days. 
Collagen galactosyltransferase assay – 107 cells were lysed in 200 µl of Tris-buffered saline, 1% Triton 
X-100, pH 7.4 for 15 min on ice. Nuclei and debris were removed by spinning at 13’000 x g for 10 min 
at 4°C and supernatants were used as enzyme source. Bovine collagen type I was heat- denatured for 
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10 min at 60°C and kept on ice until use. Activity assays included 10 µl of cell lysate, 0.5 mg/ml 
denatured collagen acceptor, 60 µM UDP-Gal, 50’000 cpm of UDP-[14C]Gal (GE Healthcare, Little 
Chalfont, UK), 10 mM MnCl2, 20 mM NaCl, 50 mM morpholinepropanesulfonic acid (pH 7.4) and 1 mM 
1,4-dithiothreitol. Reactions were incubated for 3 h at 37°C and stopped by addition of 500 µl of 5% 
trichloroacetic acid 5% phosphotungstic acid for 30 min on ice. Precipitated proteins were recovered 
on filters using a vacuum manifold, washed with 15 ml 50% ethanol and radioactivity was measured in 
a Tri-Carb 2900TR scintillation counter (PerkinElmer Life Sciences). 
Quantitative PCR analysis – Total RNA was extracted from 5x106 cells using TRIzol reagent (Life 
Technologies, Carlsbad, CA) according to the manufacturer protocol. First strand cDNA was produced 
using 2 µg of total RNA and RevertAid reverse transcriptase (Life Technologies). 10 µl of 2x SsoAdvanced 
universal SYBR Green Supermix (Bio-Rad) were mixed with 1 µl of translated cDNA and 1 µl of 10 µM 
diluted primer pair (table I) in a 20 µl reaction. Specific real-time PCR primers (Table 1) for the unfolded 
protein response were selected from Oslowski et al. [26]. Primers for collagen type I COL1A1 and 
collagen type V COL5A1 mRNA quantification were designed using the primer-BLAST software [27] and 
encompassed exon sequences flanking at least one intron. 
 
Collagen extraction – Osteosarcoma cells were grown to 70% confluency in DMEM containing 2% fetal 
calf serum, 50 µg/ml ascorbate and 50 µg/ml catalase. Ascorbate and catalase were replenished every 
48 h for 8 days. Medium and cells were collected and digested at 10 µg/ml pepsin in 1 M HCl for 6 h at 
22°C. Neutral pH was restored by addition of 1 M NaOH and collagens were precipitated in 50% ethanol 
at -20°C overnight. Collagens were resuspended in 10 ml 0.1 M acetic acid at 4°C for 48 h, then 
concentrated and purified using 100 kDa-cutoff Amicon ultra centrifugal filter units (Sigma- Aldrich). 
Collagens were diluted to 0.1 mg / ml and stored at 4°C for 72 h prior to analysis. 
 
HPLC amino acid analysis – Purified collagens (10 μg) were hydrolyzed in 500 μl of 4 M KOH at 105°C 
for 20 h. Hydrolysates were neutralized using perchloric acid. Salt precipitates were removed and 
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supernatant dried down under nitrogen, washed twice with 500 μl of water, then dried down again. 
Samples were resuspended in 100 μl of water and derivatized using 9-fluorenylmethoxycarbonyl 
chloride following the procedure of Bank et al. [28]. Derivatized amino acid samples were analyzed by 
reverse phase HPLC [18]. 
Circular dichroism – Purified collagens were diluted to 0.1 mg/ml in 0.1 M acetic acid. Ellipticity was 
measured between 210 and 250 nm in a spectropolarimeter (J-810, Jasco) with a thermostated quartz 
cuvette with 1 mm length. Thermal stability was analyzed at 222 nm under heating at a rate of 0.5°C/min 
from 30 to 50°C. 
Immunofluorescence – Cells were grown on sterile 11 mm glass coverslips for 48 h, then fixed in 4% 
paraformaldehyde in phosphate-buffered saline (PBS) for 15 min at room temperature, then 
permeabilized with 0.5% saponin for 10 min at room temperature. Cells were incubated with 5% bovine 
serum albumin (Sigma-Aldrich) for 1 h, then with primary antibodies diluted in PBS, 0.05% Tween, 1% 
bovine serum albumin for 1 h. After three wash steps in PBS, 0.05% Tween, cells were incubated with 
secondary antibodies for 1 h at room temperature. Cells were washed three times in PBS and nuclei 
were stained with DAPI (Biotium, Hayward, CA). Coverslips were mounted on ProLong Gold antifade 
medium (Life Technologies). Antibodies used were mouse anti-collagen type I (ab6308, Abcam, 
Cambridge, UK), rabbit anti-collagen type I (ab34710, Abcam), goat anti-collagen type III (ab24129, 
Abcam), rabbit anti-collagen type V (ab7046, Abcam), rabbit anti-GLT25D1 (ab151011, Abcam), mouse 
anti-PDI(RL90) (Alexis 804-012, Enzo Life Sciences, Lausen, Switzerland) and rabbit anti-giantin 
(ab24586, Abcam). The secondary antibodies used were goat anti-mouse 647 (ab150119, Abcam), goat 
anti-rabbit 488 (ab150077, Abcam) and donkey anti-goat 488 (ab150129, Abcam). 
Image Acquisition and channel intensity quantification – Coverslips were imaged using a confocal 
laser scanning microscope type Leica TCS SP8 using a HCX PL APO CS2 oil objective lens at 63x 
magnification, f1.4 numerical aperture at room temperature. The fluorophores DAPI, Alexa 488 and 
Alexa 647 were excited sequentially at 405, 488 and 638 nm, respectively. The spectral emission 
detection unit was set between 415 nm and 525 nm for DAPI, between 495 nm and 590 nm for Alexa 
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488 and between 645 nm and 750 nm for Alexa 647. Images were recorded at a resolution of 1400 x 
1400 pixels at 1000 Hz, line average = 3 and z-stacks (~25) height was set to system optimized by the 
software. Images were recorded using two hybrid detectors using the Leica LAS X software (Leica 
Microsystems AG, Heerbrugg, Switzerland). 3D images were projected to 2D using Imaris 7 (Bitplane 
AG, Switzerland) with the according MATLAB plugin (MathWorks, Bern, Switzerland) using MIP 
projection on x-y plane. Channel intensities were quantified using ImageJ 1.50B [29] as described [30]. 
Western Blot analysis – 5x106 cells were lysed in RIPA lysis buffer for 30 min on ice, then spun for 15 
min at 13000 x g at 4°C. Amounts of 20 µg of whole protein lysates were resolved on 10% SDS-PAGE. 
Proteins were blotted on a nitrocellulose membrane (GE Healthcare) and blocked in 5% skim milk 
powder in PBS for 1 h. Membranes were incubated overnight at 4°C with anti-GLT25D1 antibody at 
1:250 (ab151011, Abcam), anti-collagen type I at 1:10’000 (ab138492, Abcam) or anti-β-tubulin I at 
1:10’000 (Sigma-Aldrich) in Tris-buffered saline, 0.05% Tween, 1% bovine serum albumin. Secondary 
goat anti rabbit or goat anti mouse antibodies coupled to horseradish peroxidase at 1:10’000 (Sigma- 
Aldrich) were diluted in Tris-buffered saline, 0.05% Tween and incubated for 1 h at room temperature. 
Pulse chase labelling of collagens – Cells were plated in 6-well plates at 2.5 x 105 cells per well and 
incubated for 24 h at 37°C. Medium was exchanged with DMEM (Sigma Aldrich) with 10% fetal bovine 
serum (Biochrom AG) containing 50 µg/ml ascorbate and 50 µg/ml catalase and cells were incubated 
overnight at 37°C. Cells were washed once in PBS, then pulsed in 1 ml of DMEM, 50 µg/ml ascorbate, 
20 µCi/ml L-[14C(U)]-proline (Perkin Elmer, Waltham, MA) for 4 h. Chase was initiated by changing 
medium to DMEM, 50 µg/ml ascorbate, 30 µg/ml L-proline. Secreted and cellular collagens were 
digested in the cell medium using 25 µg/ml pepsin in 1 M HCl for 2 h at 4°C. Neutral pH was restored by 
addition of 1 M NaOH and collagens were precipitated in 50% ethanol at -20°C overnight, then 
resuspended in Laemmli buffer. Collagens were separated in 9% SDS-PAGE and blotted on nitrocellulose 
membrane (GE Healthcare) prior to autoradiography. Band intensity was quantified using the open 
source software ImageJ [29] with the gel-analyzer plugin. 
 78 
2.2.4 RESULTS 
GLT25D1 and GLT25D2 inactivation in osteosarcoma cells 
 
Collagen glycosylation is initiated by the transfer of Gal to Hyl catalyzed by GLT25D1 and GLT25D2 
galactosyltransferase enzymes. To identify osteosarcoma cell lines generating high amounts of collagen 
galactosylation, we first analyzed GLT25D1 and GLT25D2 gene expression in the three collagen 
producing osteosarcoma cell lines SaOS-2, MG63 and U2OS [31]. As expected, GLT25D1 was the main 
collagen galactosyltransferase isoform expressed in osteosarcoma cells considering the restricted 
expression of GLT25D2 in brain and skeletal muscle [12]. The transcript levels of GLT25D2 represented 
only 1 to 4% of GLT25D1 levels in the three cell lines investigated (Fig. 1A). As a comparison, the PLOD3 
gene encoding the lysyl hydroxylase 3 enzyme was expressed between 0.5 to 2-fold the levels of 
GLT25D1 transcripts (Fig. 1A). The three collagen-modifying genes were expressed at the highest levels 
in SaOS-2 cells. Considering the strong expression of collagen galactosyltransferases and lysyl 
hydroxylase 3 genes in SaOS-2 cells, as well as the prominent production of collagen type I and highly 
glycosylated collagen type V in these cells [32], we primarily investigated the role of collagen 
glycosylation in SaOS-2 cells. 
The GLT25D1 and GLT25D2 galactosyltransferase genes were inactivated in SaOS-2 cells using the 
CRISPR/Cas9 system [33]. The exons 7 to 10 of GLT25D1 and the exons 7 to 12 of GLT25D2 encode the 
GT25 domain required for galactosyltransferase activity (Fig. 1B). We therefore targeted exon 2 to 
disrupt GLT25D1 and exon 3 to disrupt GLT25D2. To control for annealing specificity, we used a gRNA 
sequence nearly identical to the GLT25D1-targeting gRNA by including a single base mismatch (Fig. 1C). 
We obtained two cell clones with genomic mutations at the expected locus of GLT25D1 and one cell 
clone with a mutation in GLT25D2. Sanger sequencing of the targeted GLT25D1 exon 2 revealed a 
homozygous mutation in the first cell clone and compound heterozygous mutations in the second cell 
clone. Sequencing of GLT25D2 exon 3 confirmed a homozygous point mutation at the expected genomic 
location (Fig. 1C). The frame-shift mutations detected in the GLT25D1 clones yielded truncated open 
reading frames that lack the catalytic GT25 domain. To obtain cell clones containing both GLT25D1-null 
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and GLT25D2-null genes, we transfected GLT25D1-null cells with the CRISPR/Cas9 construct targeting 
the GLT25D2 exon 3, which was successfully applied to disrupt GLT25D2. After screening 100 cell clones, 
we identified 14 clones carrying a single mutated GLT25D2 allele but none that carried GLT25D1 and 
GLT25D2 genes inactivated on both alleles. SaOS-2 cells transfected with the mismatch control gRNA 
construct did not yield any genomic mutation in the GLT25D1 targeted region after screening 10 cell 
clones. These 10 cell clones were pooled and used as control cells in subsequent experiments. The loss 
of GLT25D1 protein expression in SaOS-2 cells bearing inactivating mutations was confirmed by Western 
blotting (Fig. 1D). Changes in GLT25D2 protein levels could not be assessed because GLT25D2 remained 
undetectable by Western Blot analysis in the three osteosarcoma cell lines tested. The inactivation of 
the GLT25D1 gene yielded a strong decrease of collagen galactosyltransferase activity down to 3-7% of 
the reference activity in native SaOS-2 cells and in the transfection control (Fig. 1E). Stable 
overexpression of a GLT25D1 cDNA transgene in GLT25D1-null cells increased collagen 
galactosyltransferase by 6 to 8-fold. By contrast, the inactivation of GLT25D2 in SaOS-2 cells only 
marginally decreased collagen galactosyltransferase activity to 92% of control values (Fig. 1E), thereby 
confirming GLT25D1 as the main enzyme mediating collagen galactosylation in SaOS-2. Taken together 
these data confirmed the successful functional inactivating role of the introduced mutations. 
 
GLT25D1 inactivation upregulates GLT25D2 and COL1A1 mRNA levels 
 
GLT25D1 mRNA levels were significantly reduced in GLT25D1-null cells indicating induction of mRNA 
nonsense-mediated decay [34] (Fig. 2A). GLT25D1 mRNA levels were increased by 25% in GLT25D2- 
null cells, suggesting a possible compensatory effect by GLT25D1 upon inactivation of GL525D2. 
Correspondingly, GLT25D2 was upregulated 3- to 5-fold in GLT25D1-null cells (Fig. 2B). Interestingly, 
GLT25D2 expression was also increased in GLT25D1-null cells overexpressing a GLT25D1 cDNA 
transgene. As documented in a recent study, functional inactivation of single genes often results in 
compensatory overexpression by paralogous genes [35]. Whereas GLT25D2 expression showed such a 
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compensatory pattern, PLOD3 expression remained unchanged upon GLT25D1 and GLT25D2 
inactivation (Fig. 2C), indicating that loss of collagen galactosyltransferase activity did not lead to 
increased lysyl hydroxylase gene expression. Surprisingly, GLT25D1 inactivation induced a strong 
expression of the COL1A1 gene encoding a collagen type I polypeptide (Fig. 2D). Normal COL1A1 
expression was restored to control levels in GLT25D1-null cells upon overexpression of a GLT25D1 
cDNA transgene, indicating that collagen galactosyltransferase activity was critical in regulating COL1A1 
expression. Accordingly, COL1A1 mRNA levels were normal in GLT25D2-null cells (Fig. 2D). The impact 
of collagen galactosyltransferase activity on collagen expression was specific to COL1A1 as COL5A1, 
encoding a collagen type V polypeptide, was insensitive to GLT25D1 and GLT25D2 alterations (Fig. 2E). 
 
Collagen glycosylation in GLT25D1-null cells is partially restored by GLT25D2 
 
To quantify the compensatory effect of GLT25D2 on collagen glycosylation in GLT25D1-null cells, we 
determined collagen post-translational modifications in endogenously produced collagen by amino 
acid analysis. The amount of glycosylated Hyl carrying the Glc( 1-2)Gal disaccharide was reduced in 
GLT25D1-null cells by 42 to 60% (Fig. 3A, B). Levels of free Hyl was correspondingly elevated in 
GLT25D1-null cells. Alterations of collagen folding result in over-modification of collagen because of 
extended exposure of collagen substrates to prolyl hydroxylases in the endoplasmic reticulum (ER) 
compartment [36,37]. Here, we did not detect any difference in hydroxyproline levels in GLT25D1- null 
collagen compared with collagen from control cells, suggesting a normal rate of collagen folding in 
GLT25D1-null cells. 
Defects of triple helix formation because of altered post-translational modifications of collagen often 
impair the trafficking of collagens [7,38]. Under physiological conditions, only triple helical collagen is 
secreted, indicating that collagen secretion is directly proportional to triple helix formation [39]. We 
assessed the triple helical conformation of endogenous collagen in control and GLT25D1-null cells using 
circular dichroism. The ellipticity spectra showed the typical peak at 222 nm as well as a minimum under 
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200 nm in both control and GLT25D1-null cells (Fig. 3C). Thermal stability was 
determined by monitoring changes in ellipticity at 222 nm during heating collagen from 30°C to 50°C. 
Both collagens extracted from GLT25D1-null and control cell lines exhibited similar thermal properties 
with a normal melting temperature of 43.2°C (Fig. 3D). These results indicated that decreased collagen 
glycosylation did not alter collagen folding and thermal stability. 
 
ER accumulation of collagen type I in GLT25D1-null cells 
 
To confirm the increased collagen type I production in GLT25D1-null cells at the protein level, we first 
analyzed intracellular collagen amounts and distribution in control, GLT25D1- and GLT25D2-null SaOS-
2 cells. In GLT25D1-null cells, collagen type I levels reached 150 to 190% of control values as measured 
by immunofluorescent channel intensity (Fig. 4A, B). Collagen type I levels normalized upon GLT25D1 
cDNA overexpression in GLT25D1-null cells. As noted for COL1A1 mRNA levels, inactivation of GLT25D2 
did not alter intracellular collagen type I amounts. The increased collagen type I levels detected by 
immunofluorescence were further confirmed by Western Blot analysis (Fig. 4C). Collagen expression in 
GLT25D2-inactivated cells was equal to control cells and to GLT25D1 cDNA-overexpressing GLT25D1-
null cells (Fig. 4A), indicating a minor impact of GLT25D2 inactivation on collagen expression. 
Even though collagen type V contains 10 times more glycosylated Hyl residues than collagen type I [40], 
increased cellular amounts were only visible for collagen type I. Immunofluorescent staining for 
collagens type III and V remained unchanged in GLT25D1-null cells (Fig. 5A). Inactivation of GLT25D1 
may only affect collagen type I levels because this type of collagen is by far produced at highest amounts 
in SaOS-2 cells. To verify an impairment of collagen translocation, we colocalized collagen type I with 
the ER marker protein disulfide-isomerase (PDI). Elevated collagen type I levels were clearly associated 
with the ER compartment as shown by colocalization with PDI (Fig. 5B). Staining of SaOS-2 cells with the 
Golgi marker giantin showed a dilatation of Golgi stacks and co-localization with collagen type I, thus 
indicating the translocation of collagen type I from the ER to the Golgi (Fig. 5C). 
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Increased collagen type I does not induce ER stress 
 
The intracellular accumulation of collagen type I and the occurrence of possibly improperly folded 
collagens could induce ER stress and thereby an unfolded protein response [41] in GLT25D1-null cells. 
To assess the possible induction of an unfolded protein response, we measured splicing of XBP1 (Fig. 
6A, B), the mRNA levels of GRP78 (Fig. 6C) and ATF4 (Fig. 6D) as markers of the unfolded protein 
response. Tunicamycin was used as a positive control to induce the unfolded protein response [26]. 
Whereas tunicamycin treatment induced a robust unfolded protein response in control and 
GLT25D1-null cells, the three markers investigated remained unchanged in GLT25D1-null cells under 
conditions of collagen type I ER accumulation (Fig. 6A-D). The absence of unfolded protein response in 
GLT25D1-null cells indicated that the accumulation of collagen type I was not related to impaired 
collagen folding in the ER and delayed transfer to the Golgi apparatus. As the accumulation of collagen 
type I could be related to delayed collagen secretion, we quantified collagen production and secretion. 
The main types of collagen secreted by SaOS-2 cells are collagen type I and the highly glycosylated 
collagen type V [31]. Both control and GLT25D1-null cells produced and secreted these two typed of 
collagens normally as assessed by pulse-chase experiments (Fig. 7A,B). Collagen degradation (Fig. 7C) 
and secretion rates (Fig. 7D) remained normal in GLT25D1-null cells, thus showing that loss of GLT25D1 
did not alter collagen secretion. 
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2.2.5 DISCUSSION 
 
The inactivation of collagen galactosyltransferase GLT25D1 and GLT25D2 genes in osteosarcoma cells 
delineated the role of glycosylation in collagen expression and intracellular trafficking. Defective 
glycosylation had no impact on the rate of collagen secretion and triple helix thermal stability. By 
contrast, the loss of the main collagen galactosyltransferase isoform GLT25D1 led to ER accumulation 
of collagen type I in SaOS-2 cells. The intracellular accumulation of collagen type I resulted from 
increased collagen type I gene expression induced by low collagen galactosyltransferase activity. In 
addition, GLT25D1 inactivation was compensated at the transcriptional level by induction of GLT25D2, 
which is normally hardly expressed in osteosarcoma cells. 
Genetic compensation consecutive to gene inactivation is an effect that has previously been described 
in animals and plants such as Arabidopsis [35]. Accordingly, compensation by induction of paralogous 
genes often occurs in parallel to lethal mutations [42]. Our results on the induction of GLT25D2 in 
GLT25D1-null cells are in agreement with such a compensatory reaction and underline the necessity to 
inactivate both collagen galactosyltransferase isoforms in order to obtain a complete loss of collagen 
glycosylation. Our failure to isolate cell clones harboring both inactive GLT25D1 and GLT25D2 genes 
supports the notion that collagen glycosylation is essential for osteosarcoma cell viability and that the 
induction of GLT25D2 is required to prevent the complete loss of collagen galactosyltransferase activity 
when the main GLT25D1 isoform is disrupted. 
The inactivation of GLT25D1 led to the upregulation of collagen type I expression, which is the main 
type of collagen produced in SaOS-2 cells. Upregulation of collagen type I in response to mutation of 
the post-translational machinery is also seen in fibroblasts from Bruck syndrome type 2 patients, in 
which mutations in PLOD2 encoding the lysyl hydroxylase 2 isoform decrease the level of telopeptide 
lysyl hydroxylation and thereby the formation of telopeptide-based intermolecular crosslinks [9]. By 
contrast, hyper-modification of collagen, as observed in osteogenesis imperfecta caused by delayed 
collagen folding, does not increase collagen type I production [43,44]. The capping of Hyl by 
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glycosylation may act as a signal for the packaging of folded collagen into vesicular structures [45] in 
order to be transported to Golgi cisternae. Other classes of glycosylation, such as N-linked 
glycosylation, also convey signals for folded glycoproteins to depart the ER compartment [46]. 
Carbohydrate-binding proteins, such as ERGIC53 [47], recognize glycan chains on glycoproteins and 
mediate their transfer to the cis-Golgi compartment. 
Collagen type I is regulated by various factors including interleukins, insulin-like growth factor-1 and 
transforming growth factor-β [48]. Mice deficient for β1-integrin lack feedback regulation of collagen 
synthesis [49]. Since glycosylation was shown to impact collagen-integrin interaction, integrins may be 
involved in the collagen type I upregulation seen in GLT25D1-null cells by modulated binding of collagen 
to integrin and subsequent alteration of transforming growth factor-β signaling. Another collagen 
interacting receptor, uPARAP, also depends on collagen glycosylation for matrix remodeling. uPARAP 
mediates the preferential endocytosis of glycosylated collagen IV and V [19,50]. uPARAP itself has no 
direct regulatory function in collagen expression since uPARAP-/- mice show normal collagen 
production. Nevertheless, uPARAP could be regulating collagen homeostasis by altered collagen uptake, 
thereby changing the intracellular collagen pool and making it available for intracellular feedback 
regulation. 
Collagen glycosylation is conserved in the animal kingdom from sponges to humans [14-17], 
suggesting an important contribution of glycosylation to collagen properties in the extracellular 
matrix. In addition to the intracellular functions investigated in the present study of osteosarcoma 
cells, glycosylation may be involved in the organization of collagens in the extracellular space. 
Glycosylation has been suggested to regulate crosslink formation in fibrillar collagens [51]. Also, the 
glycosylation of collagenous domains of adiponectin, serum mannose-binding lectin, and complement 
factor C1q has been involved in the control of subunit oligomerization [52,53]. Whereas the present 
study uncovered an unexpected link between collagen glycosylation and collagen type I expression in 
osteosarcoma cells, the inactivation of GLT25D1 and GLT25D2 in model organisms will be required to 
uncover the role of collagen glycosylation in shaping the extracellular matrix. 
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Figure Legends 
 
Figure 1: Characterization of GLT25D1 and GLT25D2 inactivation in osteosarcoma cell lines. A) 
Real-time PCR analysis of GLT25D1, GLT25D2 and PLOD3 relative to GAPDH expression levels in SaOS- 
2, MG63 and U2OS cells. B) Representation of GLT25D1 and GLT25D2 gene structure. Dashes mark 
exons, blue dashes mark the gRNA target region, red dashes mark the glycosyltransferase coding region. 
C) Sequences of gRNAs targeting GLT25D1 and GLT25D2 and sequences of the targeted segment in cell 
clones transfected with control gRNA (C), with gRNA targeting GLT25D1 (D1a, clone 1; D1b, clone 2), and 
GLT25D2 (D2). D) Western blot of GLT25D1 in GLT25D1-null cells with and without overexpression of 
GLT25D1 cDNA (rGLT25D1). E) Galactosyltransferase activity in lysates of control (C), GLT25D1-null (D1a, 
D1b) and GLT25D2-null (D2) cells with and without GLT25D1 cDNA (rGLT25D1) overexpression. 
 
Figure 2: Transcription analysis of collagen and collagen modifying enzymes. Real-time PCR analysis 
was performed on GLT25D1-null (D1a, D1b), GLT25D2-null (D2) and control (C) cell lines with and 
without GLT25D1 (rGLT25D1) overexpression. Primers specific for A) GLT25D1, B) GLT25D2, C) PLOD3 
D) COL1A1 and E) Col5A1 were used. Statistically significant differences as determined by two tailed 
student’s t-test (p<0.05) are marked by stars. 
 
Figure 3: Analysis of collagen post-translational modifications and triple helical stability. A) Amino 
acid analysis of collagens extracted from control (C) and GLT25D1-null cells (D1). Collagens were 
alkaline-hydrolysed and FMOC-labelled before separation by HPLC. Hyp: hydroxyproline, GG-Hyl: 
glucosylgalactosyl-hydroxylysine, Hyl: hydroxylysine. B) Zoom of region containing glycosylated Hyl. 
C) Circular dichroism of collagens extracted from control (C) and GLT25D1-null (D1) cell lines. Spectra 
were recorded at 10°C between 210 and 250 nm in a spectropolarimeter. D) Thermal transition of 
control (C) and GLT25D1-null (D1) collagens in 0.1 M acetic acid. Temperature was raised from 30°C to 
50°C with 0.5°C/min. Tm value was calculated at 50% triple helical signal. 
 
Figure 4: Immunofluorescent analysis. A) Collagen type I and GLT25D1 staining in control (C), GLT25D1-
null (D1a, D1b), and GLT25D2-null (D2) cells with and without overexpression of GLT25D1 cDNA 
(+GLT25D1). White arrows mark cells expressing the transfected GLT25D1 cDNA. Scale bar equals 10 µm. 
B) Quantification of collagen type I channel intensity based on 50 cells. Stars above bars indicate 
statistically significant differences based on two-tailed paired t-test (p<0.05). C) Western blot of collagen 
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type I in GLT25D1-null (D1a, D1b), GLT25D2-null (D2), control (C) and GLT25D1 cDNA (+rGLT25D1) 
overexpressing cells. One representative experiment is shown (total n=3 independent experiments).  
 
Figure 5: Immunofluorecent analysis of collagen type III and V and colocalization of collagen type I with 
ER and Golgi. A) Immunofluorescent staining of control (C) and GLT25D1-null (D1) cells with anti-collagen 
type V and anti-collagen type III antibodies (red). B) Colocalization of collagen type I (red) and the ER 
marker PDI (green). C) Colocalization of collagen type I (red) and the Golgi marker giantin (green). White 
arrows point to Golgi and collagen type I positive region. 
 
Figure 6: Analysis of the unfolded protein response. A-D) Real-time PCR analysis of RNA extracted from 
control (C) and GLT25D1-null (D1) cells. Specific primers for A) XBP1, B) spliced XPB1, C) GRP78 and D) 
ATF4 were used with or without induction of the unfolded protein response using tunicamycin (TMC). 
Statistically significant differences as determined by two tailed student’s t-test (p<0.05) are marked by 
stars (n=3 independent experiments). 
 
Figure 7: Analysis of collagen secretion. A-D) Pulse chase analysis of collagens from control (C) (A) and 
GLT25D1-null (D1) (B) cells after pulse period of 4h. Collagen bands were quantified for cellular collagen 
(C) and for secreted collagens (D) using imageJ. One representative experiment is shown (total n=3 
independent experiments). 
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Table I. Primer pairs used for amplification in real-time PCR reactions. 
 
Gene Forward primer Reverse Primer 
COL1A1 5’-GCTCGTGGAAATGATGGTGC-3’ 5’-ACCCTGGGGACCTTCAGAG-3’ 
COL5A1 5’-CTTGGCCCAAAGAAAACCCG-3’ 5’-TAGGAGAGCAGTTTCCCACG-3’ 
GAPDH 5’-CGCTCTCTGCTCCTCCTGTT-3’ 5’-CCATGGTGTCTGAGCGATGT-3’ 
spliced XBP1 5’-TGCTGAGTCCGCAGCAGGTG-3’ 5’-ATCCATGGGGAGATGTTCTGG-3’ 
unspliced XBP1 5’-CAGCACTCAGACTACGTGCA-3’ 5’-TGGCCGGGTCTGCTGAGTCCG-3’ 
ATF4 5’-GTTCTCCAGCGACAAGGCTA-3 5’-ATCCTCCTTGCTGTTGTTGG-3’ 
GRP78 5’-TGTTCAACCAATTATCAGCAAACTC-3’ 5’-TTCTGCTGTATCCTCTTCACCAGT-3’ 
GLT25D1 5’-ACTCACGCTACGAGCATGTC-3’ 5’-GTGTCAGGGTTGAGGATCAG-3’ 
GLT25D2 5’-ACTATGGCTACCTGCCCATC-3’ 5’-GGGACAACTGAGACATACTG-3’ 
PLOD3 5’-AGAACCTCAACGGGGCTTTA-3’ 5’-CTTAGTGGGACCGTTTCCAT-3’ 
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3. GENERAL DISCUSSION 
3.1 CONCLUSIONS 
 
In the current thesis, we describe the first functional study concerning collagen galactosyltransferases, 
the identification and analysis of collagens in giant viruses and the development of a bacterial expression 
system for posttranslationally modified human collagen using viral enzymes.   
Collagen glycosylation has been poorly understood even though it was first described more than 80 years 
ago [176]. Glycosylation is a ubiquitous posttranslational modification but due to the elaborate methods 
required for analysis often neglected. Studies on the function of glycosylation require identification of 
the glycosyltransferase corresponding to the posttranslational modification. GLT25D1 and GLT25D2, the 
collagen galactosyltransferases, have only been identified in 2008 [177] and consecutive functional 
studies have not yet been performed. Glucosylation of galactosylated collagens was claimed to be 
conferred by lysyl hydroxylase 3. Lysyl hydroxylase 3 is supposedly a bifunctional enzyme accomplishing 
lysyl hydroxylation and collagen glucosylation. Most studies mutated either the lysyl hydroxylase domain 
or the glycosyltransferase domain to identify specific deterioration of either enzymatic activity. A recent 
finding of a connective tissue disorder led to the identification of mutations in PLOD3 either in the lysyl 
hydroxylase domain in one allele or in the glycosyltransferase domain in the other allele [58]. 
Recombinant expression of the lysyl hydroxylase 3 with mutation in the glucosyltransferase domain 
resulted in impaired lysyl hydroxylase activity (>50%) compared to wild type lysyl hydroxylase 3. It is 
hence undistinguishable whether the reported defective secretion and accumulation of collagen type IV 
in mutated lysyl hydroxylase 3 mice [178] arise from the glycosyltransferase activity or from the lysyl 
hydroxylase activity, even if there is only one point mutation inserted in the glycosyltransferase domain. 
Follow up studies were mostly performed on purified LH3. Thereby, glucosyltransferase activity from a 
possible unidentified endogenous collagen glucosyltransferase could remain undetected. This hypothesis 
is further fortified by the fact that organisms lacking lysyl hydroxylase 3 (i.e. sponges, chicken) still carry 
collagen galactosyl-glucosylation. Missing identification of the collagen galactosyltransferases combined 
with the supposed bi-functionality of the collagen glucosyltransferase were so far responsible for the 
poor characterization of collagen glycosylation.  
For the first time, we described a functional study involving GLT25D1 and GLT25D2 and thereby changed 
collagen glycosylation in osteosarcoma cell lines. We showed a compensation mechanism in GLT25D1-
null cells by GLT25D2 and upregulated collagen type I expression. Many carbohydrates are known to be 
crucial for receptor binding and intracellular signal transduction such as N-glycosylation in integrins [179], 
binding of selectins to their ligands [180] or various roles in immune responses such as the regulation of 
IgG function by galactosylation or sialylation [181]. Hence, it is plausible that collagen glycosylation is 
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involved in collagen homeostasis. Collagens are regulated by a complex network of regulatory factors. 
Among others, TGF-β, IFN-γ, IL-1β, IFN-γ and TNF-α are known to upregulate collagen synthesis [182]. It 
is therefore not possible to predict the factors being involved in glycosylation mediated collagen 
regulation with the available data and further experiments will be necessary. 
We found an upregulation of GLT25D2 in GLT25D1-null cells. Interestingly, GLT25D2 remained 
upregulated even if recombinant GLT25D1 was overexpressed in GLT25D1-null cells. The regulation of 
the galactosyltransferases is consequently not controlled on protein or mRNA levels. GLT25D1 and 
GLT25D2 could be regulated via an epigenetic mechanism. Epigenetic imprinting is involved in regulation 
of the expression of many genes [183]. An epigenetic switch can be reversible, but also cases of 
irreversible suppression or induction of gene expression have been described [184]. DNA methylation is 
one possible mechanism by which gene translation is inhibited. Promoter regions of about 40% of all 
human genes contain CpG islands with an atypically high frequency of CpG sites [185] which were 
previously described as unmethylated [186]. Recent studies, however, showed the involvement of 
methylation in CpG islands in promoters of e.g. tumor-suppressor genes in cancer [187] and even 
collagens and collagen modifying enzymes were shown to be regulated epigenetically [188]. The 
promoter region of GLT25D1 and GLT25D2 contain CpG islands (Fig. 12). Therefore, GLT25D2 might be 
suppressed by methylation in wild type state (Fig. 9) and activated upon GLT25D1 inactivation. Even 
though experimental evidence is missing, an irreversible epigenetic switch could explain the upregulation 
of GLT25D2 in GLT25D1-null cells and maintenance of upregulated GLT25D2 levels in GLT25D1-null cells 
with overexpression of recombinant GLT25D1.  
 
Many collagen-modifying enzymes are essential and result in severe disorders of bones and connective 
tissue if mutated. Some of the diseases have been described earlier but could have been assigned only 
to a deficiency of specific enzymes in the last decade. Mutation in lysyl hydroxylase 1 results in the Ehlers-
Danlos syndrome VI [189], mutation in lysyl hydroxylase 2 in the Bruck syndrome [190] and mutation in 
lysyl hydroxylase 3 in a yet unnamed collagen disorder with a combination of symptoms similar to the 
Ehlers-Danlos syndrome and osteogenesis imperfecta [58].  A study from 2015 further identified the first 
mutation in the prolyl 4-hydroxylase β-subunit resulting in the Cole-Carpenter syndrome [46]. All these 
Figure 12: Identification of CpG islands in the 
promoter regions of GLT25D1 and GLT25D2. CpG 
islands are depicted in gray. The software 
EMBOSS Cpg-plot was used for identification. 
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disorders combine a series of symptoms involving fragile or malformed bones, deformed and non-
functional joints, but normal mental development.  
In C. elegans, the lysyl hydroxylase 3 homologous gene let-268 leads to embryonic lethality if knocked 
out [191] due to missing collagen type IV secretion. In contrast, the GLT25D1 and GLT25D2 homolog 
D2045.9 led to a viable phenotype consisting of slower growth, aberrant locomotion and deformed 
mating organs [192].  
Based on these findings, it is possible that a disorder of collagen glycosylation in humans exists. We 
identified a compensatory mechanism of galactosyltransferases by GLT25D2 in GLT25D1-null cells. This 
compensation could partially be responsible for an understated phenotype. GLT25D2 is mainly expressed 
in the brain, where the stability of collagen plays a minor role. Collagen α4(V), for example, serves as an 
inhibitor for axonal guidance and thereby regulates the direction of axonal outgrowth in neurons [193]. 
A link to glycosylation has not been shown. Nevertheless, collagen glycosylation in neuronal organs could 
be necessary for cellular and spatial organization and could consequently be responsible for the aberrant 
locomotive behavior of D2045.9 knock down worms.  
Collagen fibers assemble into fibrils and in supramolecular structures such as tendons, which are only 
formed in vivo and cannot be sufficiently studied in vitro. Glycosylation of collagen does not influence 
triple helix formation or their stability. Nevertheless, glycosylation could be involved in quaternary fibril 
formation, and its physiological role could become evident by studies on GLT25D1 in complex organisms 
as zebrafish or mice. There are currently 28 different types of collagen identified, of which only a fraction 
has been characterized. Further studies are essential to assess the diverse possible roles of glycosylation 
in the various collagens. 
We further identified 142 collagen-like proteins in the genomes of 60 analyzed nucleocytoplasmic large 
DNA viruses. Collagen-like genes from the Megaviridae and Mimiviridae families originated partially via 
gene duplication and share a common ancestor. In contrast, collagens from pithovirus and 
Pandoraviridae evolved via different routes and are not related. Many of the vertebrate and invertebrate 
collagens consist of a conserved, defined length of the major collagen domain of 1011 – 1020 amino acids 
containing 337 – 340 GLY-X-Y repeats [194]. The giant viruses encode longer and shorter collagen 
domains, but none of 337 – 340 GLY-X-Y repeat length. This finding supports the hypothesis that viral and 
metazoan collagens have developed co-evolutionary and exhibit different ancestors. Fibrillar collagens 
from early multicellular organisms as from sponge to humans share a common structure at the genomic 
level. The collagenous domain is encoded by exons of 54 or 45 bp length or of multiples of these modules 
[195, 196]. The modular architecture of fibrillar collagen indicates the existence of an ancient prototypic 
collagen, which was later expanded via duplications of the 54 bp exon and via unequal crossovers 
resulting in 45 bp exons [197]. All exons start with an intact codon for glycine and end with an intact 
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codon for any other amino acid. Even though giant viruses contain genomes devoid of intervening 
sequences, a similar evolution of the viral collagens to the evolution of metazoan collagens is possible. 
This hypothesis would explain the occurrence of copies of the strongly conserved interdomains. However, 
more DNA sequence data must be generated to identify an organism or virus containing the ancestral 
collagen. Megaviridae and Mimiviridae collagens share a high content of oppositely charged residues at 
the X and Y position of Gly-X-Y repeats. In humans, charged amino acids are important for the stabilization 
of fibrillar collagens with interrupted collagen domains. The length and amino acid composition of the 
viral collagen domains however do not confirm an evolutionary relationship between viral and human 
collagens. Currently only very little information is available about collagens in giant viruses. Therefore, 
the functions of viral collagens can be only hypothesized. In bacteria and in virophages, collagen-like 
proteins occur in fibers attached to the cell wall. A similar function could be hypothesized for mimivirus 
collagens. The mimivirus consists of a protein- and DNA-containing core, which is encompassed by two 
lipid membranes and a virus capsid. Several fibers are attached to the capsid [198]. The fibers are 
collagenase resistant indicating a composition of non-collagenous proteins [198]. However, proline is 
often essential in the recognition motif of collagenases to cleave collagen [199]. Considering the low 
frequency of proline in the viral proteins together with the high moiety of charged amino acids, it is 
doubtful whether the conventional collagenases can digest mimivirus collagens. The ORF L71 of mimivirus 
was shown to encode a collagen-like protein occurring on the surface of the virus [152]. It is currently 
unknown, whether L71 is part of the viral membrane or of the fibers. 
Giant viruses not only contain collagen-like proteins but also collagen modifying enzymes. We used a 
prolyl 4-hydroxylase and a bifunctional lysyl hydroxylase and glucosylatransferase from mimivirus to 
express recombinant, posttranslationally modified human collagen type III in a bacterial expression 
system. The collagens folded triple helically and the stability of triple helical collagen could be increased 
by hydroxylation.  
Collagen is used in reconstructive medicine and in cosmetics. To date, collagen of bovine or porcine origin 
is used due to a high biocompatibility. The largest segment of the market of collagens consisted of dermal 
fillers. The American society of Aesthetic Plastic Surgery Practice Survey from 2014 states about 22’049 
collagen based applications yearly in the USA. In 2000, in contrast, there were almost 600’000 
applications registered [200]. The main reason of this decay lays in the insufficient biosafety of animal 
collagens and in the development of safe alternatives. Bovine collagen type I shares 95% sequence 
identity to human collagen type I and results in allergic reactions in 1 – 3% of the applications. In contrast, 
hyaluronic acid is a polysaccharide with the structure (-4GlcUAβ1-3GlcNAcβ1-)n that is conserved among 
various species [201]. It is therefore non-immunogenic and the most used alternative to collagen as 
dermal filler today with almost 2’000’000 yearly applications in the USA. Hyaluronic acid occurs in rooster 
combs and is mainly purified from this animal source. Even after purification, avian protein impurities can 
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cause allergic reactions in patients treated with hyaluronic acid [202]. With the development of a 
recombinant expression system for hyaluronic acid in streptococcus, large scale production became 
possible [203]. These non-animal stabilized hyaluronic acid products exhibit a low risk for hypersensitivity 
reactions (<0.6%) and are therefore commonly used today. Due to the polar composition of hyaluronic 
acid, it can bind approximately 6 liters of water per gram [204]. Contrary to collagen fillers, which are the 
main structural component in collagen-based dermal fillers and provide tensile strength, hyaluronic acid 
applications are stabilized by water to replenish degraded connective tissue and provide pressure 
resistance. Hyaluronic acid can be chemically crosslinked in order to improve half-life from three to six 
months.  
With the advantages of less immunogenicity and enhanced durability compared to collagen fillers, 
hyaluronic acid is the preferred agent for dermal injections today. Nevertheless, there are novel 
formulations of crosslinked collagens which can result in a half-life of up to 12 months [205]. The 
formulation uses ribose to crosslink collagen and thereby making it less available for collagenases and 
cellular degradation. Since it is derived from pork, hypersensitivity reactions can still occur but they are 
significantly reduced compared to native porcine collagen.  
The market for dermal fillers is heavily growing and novel products based on recombinant collagens could 
colonize a niche by implementing natural advantages of collagen. Endogenous collagen in skin exhibits a 
half-life of approximately 15 years [206]. In contrast, endogenous hyaluronic acid in synovial fluids 
exhibits a half-life of only 16 hours [207]. Even if these results do not represent the stability of dermally 
injected polymers, manufacturing of collagen-based devices should be possible with superior durability 
compared to hyaluronic acid. One approach could be implemented by the stabilization of the triple helix 
by prolyl 4-hydroxylation. Fully hydroxylated collagen type I exhibits a melting temperature 16°C higher 
compared to unhydroxylated collagen [20]. The collagen triple helices might further be cross-linked via 
the lysyl oxidase. These modifications should enable the production of durable collagen based 
applications. Moreover, collagens are hemostatic [208] resulting in less bleeding and reduced swelling 
after injection compared to hyaluronic acid. In addition collagen increases cell attachment, cell 
proliferation and migration [209]. Therefore, collagen would be the preferred substrate for intradermal 
applications, if its longevity could be increased. 
Our study provides the proof of principle that production of posttranslationally modified recombinant 
human collagens in bacteria is possible. For a successful application in mice or human, several hurdles 
still have to be taken. The collagen expressed in our system is a truncated 38 kDa version of type III 
collagen. The collagen domain of full-length collagen type III however is 98 kDa and was expressed only 
in small amounts in E. coli (data not shown). By truncation, new immunogenic epitopes could be 
generated and biosafety compromised. The bacterially expressed collagens were only analyzed on the 
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level of triple-helical assembly, fibril and fiber formation have not been studied. We further used a viral 
prolyl 4-hydroxylase with different specificity compared to the human prolyl 4-hydroxylase. 
Hydroxylation of prolines in the X position of the GLY-X-Y repeats was shown to destabilize the triple 
helix. For maximal stability of the collagen triple helix, either a different prolyl 4-hydroxylase must be 
found, or the mimivirus prolyl 4-hydroxylase must be genetically modified in order to increase its 
specificity. 
To sum up, recombinant human collagen from bacterial expression harbors an enormous potential in 
cosmetic and reconstructive medicine due to high expression levels and presumably low antigenicity. 
Preliminary hurdles such as high costs of development inhibited successful commercial applications so 
far. Therefore, further research on intradermal longevity and immunogenicity are indispensable.  
 
3.2 FUTURE DIRECTIONS 
 
The findings derived from the present study on collagen glycosylation lead to several new questions. 
Collagen glycosylation is still poorly understood. Detailed characterization of the regulation of collagen 
modifying enzymes could reveal further involvements of collagen glycosylation in biological processes 
such as cell division, migration or spatial organization. We presented a link between collagen 
glycosylation and collagen expression. Further experiments could aim on a mechanistic explanation for 
that phenomenon by identifying proteins interacting with glycosylated collagen but not with non-
glycosylated collagen. Our experiments revealed new insights on collagen glycosylation on cellular and 
molecular levels. Animal models, however, could reveal novel functions of collagen glycosylation in a 
broader context during embryogenesis and, if viable, during early stages of life. Collagen glycosylation 
could also be involved in diseases of connective tissue or bone in humans. By DNA sequencing of available 
samples from patients suffering from unidentified disorders, mutations in GLT25D1 or GLT25D2 could be 
identified and further characterized.  
We identified collagen-like proteins from giant viruses with features not observed in other collagens. The 
mimi- and megavirus derived collagen-like proteins have oppositely charged amino acid residues in about 
60% of all G-X-Y repeats. While human collagens use a similar strategy to stabilize short, interrupted 
collagen domains, the viruses could also make use of the ionic interactions for triple helix stabilization. 
To prove this hypothesis, collagen-like proteins can be expressed recombinantly in bacteria and 
subsequently be analyzed. Hydroxylation of lysine residues changes the electrochemical properties of the 
collagen domains and could alter triple helix folding. The recombinant viral collagens could therefore be 
coexpressed with viral hydroxylases in order to verify the influence of lysyl hydroxylation. Many of the 
viral collagens further contain glycine rich repeats at the C-terminus. While similar stretches of glycine 
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occur in keratins and enable multimerization, expression of viral collagens with and without the C-
terminal domains could reveal the involvement of glycine-rich repeats in triple helix assembly. In bacteria, 
collagen-like proteins occur in tail fibers and facilitate adhesion to host cells. A similar function of the viral 
collagens is plausible in infection of amoeba. With the CRISPR/Cas9 system adapted for expression in 
amoeba, collagen-like genes could be knocked out from the viral genome and the functional role of viral 
collagens could be investigated.  
We used viral enzymes in order to stabilize recombinantly expressed human collagen. Recombinant 
collagens harbor a huge potential in biomedical applications due to the low immunogenicity and due to 
hemostatic properties. The viral prolyl 4-hydroxylase that we used to modify the recombinant human 
collagen does not possess the same sequence specificity as human prolyl 4-hydroxylase, which 
predominantly hydroxylates prolines at the Y-position in Gly-X-Y repeats. The effect of hydroxylation of 
proline residues at the X position on immunogenicity must be further evaluated. Many other giant viruses 
express prolyl 4-hydroxylases. It might hence be that these hydroxylases possess a different specificity 
than the mimivirus prolyl hydroxylase and would be more suitable for posttranslational modification of 
recombinant collagens. Our truncated collagen construct exhibits a melting temperature of 24°C. Full-
length collagen needs to be expressed to ensure sufficient stability at body temperature. We included 
several steps of optimization such as bacterial codon usage and supplementation of the growth medium 
with glycine and proline, but failed to express full-length collagen type III in significant amounts. 
Optimization of other growth parameters such as different bacterial strains or growth in fed-batch culture 
are necessary to ensure successful expression of full-length collagen.  
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